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ABSTRACT 
 
Identification of Significantly Regulated Genes in the Estrogen Induced Gallus gallus 
Liver Over a 24-Hour Time Course. (December 2011) 
Erica Renee Trojacek, B.S.; B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Rosemary Walzem  
 
In birds, estrogen is a strong stimulator of gene programs that regulate the 
formation of very low density lipoproteins (VLDL).  Apolipoprotein-B (ApoB) is an 
integral part of very low density lipoproteins.  In mammals, the rate of ApoB synthesis is 
controlled by post-translational means.  In contrast, estrogen treated birds show changes 
in ApoB transcript level; in a natural setting, the bird‟s metabolism and transcription are 
in great flux due to yolk formation.  Besides the ApoB gene, the entire complement of 
genes that is necessary to form a VLDL is not known.  To determine the genes that play 
a role in the formation of VLDL 7-10d old chicks were injected with estrogen at several 
time points over a 24hr period.  Following exsanguinations by cardiac puncture, livers 
were removed and RNA was extracted.  The RNA was quantified and hybridized to 
microarrays using a dual-dye system.   Slides were scanned and analyzed, and features 
were extracted.  To qualify microarray results, quantitative real time PCR (q-RTPCR) 
was done on a selection of genes. 
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Previous studies had shown that approximately 200 genes are upregulated by the 
treatment of hormone naïve chickens with estrogen.  As a result of our liver 
transcriptional profiling, we identified 1,528 genes at 1.5hrs, 1,931 genes at 3hrs, 2,398 
genes at 6hrs, 2,356 at 12hrs, and 1,713 genes at 24hrs following estrogen exposure.  We 
determined that these regulated genes include those responsible for the transcription of 
RNA used to create the gene products that serve as components of VLDL itself or that 
act in VLDL assembly.  These include genes encoding structural proteins, like ApoB, 
and genes encoding assembly-related proteins.  Of the differentially expressed genes as 
compared to time 0, there were approximately 30% which were unannotated with 
regards to function limiting conclusions.  We hope to determine the function of these 
genes and to annotate them based on this information.  
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NOMENCLATURE 
 
ApoB Apolipoprotein B 
ApoB100 Apolipoprotein B100 
FDR False discovery rate 
MTP Microsomal triacylglyceride transfer protein 
nt Nucleotide 
q-value Adjusted p-values found using an optimized FDR approach 
RER Rough endoplasmic reticulum 
SER  Smooth endoplasmic reticulum 
TAG Triacylglycerol 
VLDL Very low density lipoprotein 
VLDLy Yolk-targeted very low density lipoprotein 
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
 
Lipoprotein Particle 
Lipoproteins are macromolecular structures that are composed of phospholipid, 
cholesterol, cholesteryl esters (CE), triacylglycerol (TAG), and apolipoprotein; of these 
components, cholesterol, apolipoproteins, and phospholipids are on the surface and 
TAGs and CE are located in the core.  Different lipoprotein classes contain unique 
apolipoproteins on the surface which serve as receptor ligands, enzyme cofactors, and 
lipid transfer carriers.  In addition, the classes differ in diameter, density, and lipid 
fractions.   
Specifically, very low density lipoproteins (VLDLs) are a class of lipoproteins 
that contain triacylglyceride (TAG), phospoholipid, cholesterol, CE and the ApoB 
protein [1].  The source of the phospholipids, CE and cholesterol that make up a VLDL 
is variable, and can either be from de novo synthesis or preexisting pools [2].  Immediate 
precursors to TAGs destined for VLDL inclusion are hepatic fatty acids derived from de 
novo synthesis from acetyl CoA or from uptake of free fatty acids from the circulation 
[3].  The mass distribution of this macromolecular structure is 43.7-60.1% TAG, 11-
14.2% cholesteryl esters, 5.1-8.4% free cholesterol, 19.7-22.6% phospholipids, and 4.1-
11.1% protein [4].   
 
 
___________ 
This thesis follows the style of BMC Genomics. 
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The apolipoproteins associated with lipoproteins contribute to the lipoprotein‟s 
structure and stability.  There is a difference in molecular weight and the theoretical 
isoelectric point (pI) between the apolipoproteins (Table 1).  The primary apolipoprotein 
of TAG rich lipoproteins (VLDL, intermediate density lipoproteins (IDL), low density 
lipoproteins (LDL), and portomicrons in the chicken) is ApoB.  Each VLDL contains 
one ApoB100 molecule [5] and is 250-800 Å in diameter [6].  In addition to ApoB100, 
VLDLy in chickens contain one other apolipoprotein, very low density lipoprotein II 
(ApoVLDL-II).  In humans, VLDL can contain ApoB100, ApoE, and isoforms of  apoC 
[7]. 
Apolipoproteins have two roles in the body: structure and signaling.  Through 
these two functions, apolipoproteins provide the means for the regulated transport and 
metabolism of nutrient cargo that they convey.  Very low density lipoproteins, IDLs, 
LDLs, high density lipoproteins (HDL), and portomicrons in chickens are essential for 
normal growth and development by acting as the structures that allow dietary and de 
novo synthesized lipids to be shuttled through the blood to tissues for use as fuel or for 
storage [8-10].  In addition, these macromolecules transport essential fatty acids, fat 
soluble vitamins and hormones, pigments, phytosterols, hydrophobic bile acids, 
signaling lipids, and other elements.  The other necessary function of apolipoproteins is 
signaling; the signaling lipids transported by lipoproteins include sphingomyelin, 
ceramides, lysophosphatidylcholine, and diacylglycerides.   
Overall, lipoproteins are remarkable macromolecular structures that have unique 
characteristics for each of the density classes.  They perform vital roles in the body and 
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Table 1: Apolipoprotein characteristics.  Approximate molecular weight (MW) and 
theoretical isoelectric points (pI) of various apolipoproteins found in avian species.  
Calculations of theoretical pI were done with ExPASy. [11] 
Apolipoprotein Approximate MW 
(kDa) 
Theoretical pI 
Apo B 550 6.59 
Apo A-I 28 5.26 
Apo C-I 6.6 7.93 
ApoVLDL II 9.3 9.21 
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contain unique proteins to help carry out these roles.  The focus of this study is the 
identification of genes involved in the hepatic assembly of VLDL, which is the precursor 
particle to LDL, an atherogenic lipoprotein.   
Lipoprotein Particle Formation 
Lipoproteins can form intracellularly or extracellularly.  Hepatic VLDL synthesis 
constitutes a highly specialized form of post-translational protein modification of 
ApoB100 referred to as ApoB-LP assembly.  This assembly process occurs intracellularly 
and engages several subcellular compartments.  The complete assembly process and 
intracellular locations of ApoB-LP assembly are unknown and continue to be studied.  
However, a general outline of events broken into broad subprocesses with many 
individual steps creating two intermediate particles, is relatively well agreed upon 
(Figure 1).  The first of the two intermediate particles is the small, ApoB100 containing 
particle found in the rough endoplasmic reticulum (RER), and the second intermediate 
particle is the ApoB-less, large lipid filled particle formed within the smooth 
endoplasmic reticulum (SER).  In step 1, translation and simultaneous folding to form 
the tertiary structure of ApoB occurs.  This folding creates a lipid binding cavity that 
MTP, in step two, begins to deposit small amounts of TAG into.  Steps 3 and 4 go into 
more detail of the vital role MTP plays in transferring lipid to the first step particle.  Step 
5 depicts the completion of the first step particle and its liberation from the ribosome 
down the secretory pathway towards the SER.  The large, protein free second step 
particle then meets the first step particle in step 6.  The events leading to the formation 
of the large, ApoB-less particle are largely unknown.  The sequence of events leading to 
5 
 
assembly of TAG-rich ApoB-LP has been defined using a variety of techniques 
including in situ antibody mapping to track the subcellular movement of ApoB, pulse-
chase experiments with radioactive precursors of both lipids and proteins, and 
measurement of pertinent enzymatic activities in subcellular fractions [12].   
Alexander, Hamilton, and Havel in the late 1970‟s used electron microscope 
imaging of immuno gold particles to locate significant sub-cellular sites involved in 
ApoB-LP assembly; two broad steps were seen to encompass the assembly of an ApoB- 
LP.  The trio found that ApoB is synthesized within the RER [13] as are CE [14].  The 
TAG-rich ApoB-less particle originates in the SER where TAGs and cholesterol are 
synthesized [6].  The ER is a true membrane, and organized as a lipid bilayer.  
Orientation of the hydrophobic elements (fatty acyl chains of phospholipids and rings 
and side chains of cholesterol) of the lipid bilayer perpendicular to the surface of the 
membrane creates a hydrophobic region suitable for TAG and CE accumulation [12].  
The ability of membranes to bud off enables the vesicular mode of protein transport 
through the ER [15].  The actual initiator or nucleation event leading to VLDL assembly 
is unknown.  It is a point of contention whether VLDL assembly is most closely linked 
to the synthesis of TAG or CE [16-18].  Most likely, TAGs are at least equal to CE in 
their ability to initiate VLDL assembly in the laying hen [12]. 
The first step ApoB-lipid complex converges with the ApoB-free TAG-rich core 
second step particle formed within the SER [12].  Chaperone proteins are likely involved 
in this convergence.  Studies in cultured cells found the chaperone proteins glucose 
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Figure 1. General outline of the two step model of VLDL assembly.  Lipid is added 
to ApoB co-translationally, mediated by MTP.  After release from the ribosome, the first 
step particle travels to the junction of the SER.  It can then fuse with the large TG 
containing second step particle forming mature VLDL. [19] 
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regulated protein 94 kDa, glucose regulated protein 78 kDa, calreticulin, and cyclophilin 
B active in ApoB folding [20].  In addition to chaperone proteins, intracellular lipid 
transporters and nuclear factors are expected to be involved in ApoB-LP assembly, such 
as hepatic nuclear factor-α (HNFα) and sterol regulatory element-binding protein 
cleavage-activating protein (SCAP) [21, 22].  ApoB100 translocation across the ER 
membrane creates a steady-state pool of membrane-associated ApoB [1].  A major 
determinant of the ApoB100 translocation is the microsomal TAG transfer protein (MTP), 
an ER luminal protein with lipid transfer activity [1].  It is thought that the MTP protein 
is located at the site of ApoB translocation and facilitates regulated transfer of lipids and 
folding of ApoB as it exits the ribosome and enters the ER lumen [23].  It is expected 
that MTP gene expression will increase following estrogen treatment: this theory is 
directly testable. 
Specialized tubules transport the particle, now a nascent lipoprotein, to the Golgi 
apparatus where concentration occurs in secretory vesicles [6].  These secretory vesicles 
transfer to the sinusoidal surface where the particles are secreted into the space of Disse 
by fusion of the vesicular membrane with the plasma membrane of the hepatocytes [6].  
In both male and immature female birds, dietary and liver-synthesized fats leave the 
liver as TAG-rich VLDL for metabolism by extrahepatic tissues [12]. 
  Clearly the assembly of a VLDL is a complex, multi-variable process.  The 
exact details of this process are not wholly known.  A candidate gene method was 
utilized as our strategy to identify candidates in a first-pass approach to assess gene 
involvement in assembly.  Candidate genes were selected according to reports in the 
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peer-reviewed literature that, when the gene in question was absent or altered VLDL 
assembly failed or was otherwise compromised, the gene was shown or speculated to be 
involved in assembly of an apoB-LP or to be a structural part of an apoB-LP, the gene 
was shown or speculated to be estrogen responsive, or the gene was responsible for a 
protein involved in making lipids or transporting lipids.  This list of candidate genes is 
shown in Table 2.  
VLDLy 
VLDLy is a remarkable lipoprotein species that is unique to oviparous species 
and has a complex assembly process.  VLDLy depend on estrogen exposure for specific 
assembly.  VLDLy contain two lipoproteins, ApoB100, which is regulated 
transcriptionally in birds: a unique trait as compared to mammals, and ApoVLDL-II [1].   
In laying hens, VLDLy are synthesized to deliver all TAG contained in the yolk-
follicles during egg production [12].  Enrichment in TAG and smaller diameter (30nm vs 
60nm) than VLDL allows for this specialized yolk deposition [24].  It has been proposed 
that the small diameter of VLDLy avoided the probable size exclusion properties of the 
granulosa basal lamina of the ovarian follicle [25].  In actively laying hens, the uniform 
diameter of 30 nm diameter is indicative of VLDLy synthesis and secretion [12].   
In a natural egg-laying cycle, estrogen and progesterone produced by the ovarian 
follicles initiate and control VLDLy synthesis and egg production [12].     
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Table 2: Candidate genes grouped by differential expression as compared to 
time 0.  
 
Genes With Significant Change Genes Without Significant Change 
Fatty Acid Synthase (FAS) Sterol Regulatory Element Binding 
Protein Cleavage-Activating Protein 
(SCAP) 
Diacylglycerol O-Acyltransferase 2 
(DGAT2) 
Sterol Regulatory Element Binding 
Protein (SREBP) 
Glycerol-3-phosphate acyltransferase-2 
(AGPAT-2) 
ATP citrate lyase (ACLY) 
Glycerol-3-phosphate acyltransferase-3 
(AGPAT-3) 
Acetyl-CoA Carboxylase (ACC) 
Thyroid hormone responsive spot 14 
(THRSP) 
Stearoyl CoA desaturase (D9D) 
Ferritin repressor protein (aconitase 1) Fatty acid elongase (ELOVL) 
Cytochrome P450, family 51 (CYP51) 6-phosphogluconate dehydrogenase 
(PGD) 
Squalene synthase (FDFT1) Protein Kinase, AMP-activated, beta 2 
(PRKAB2) 
3-hydroxy-3-methylglutaryl-Coenzyme 
A synthase 1 (HMGCS1) 
Hepatic Nuclear Factor alpha (HNFα) 
Microsomal Triglyceride Transfer 
Protein (MTP) 
Vitamin D3 receptor (VDR) 
Heat Shock Protein 70 (HSP-70) Calreticulin (CALR) 
Heat Shock Protein 90 kDa beta 
(GRP94) 
Acetyl-CoA Acetyltransferase 1 
(ACAT1) 
Heat Shock 70kDa Protein 5 (HSPA5) Acetyl-CoA Acetyltransferase 2 
(ACAT2) 
Heat Shock Protein Cognate Beta 
(HSPCB) 
Carboxylesterase B (CES2) 
Apolipoprotein B (ApoB) ADP-ribosylation factor 1 binding protein 
(ARF1BP) 
Riboflavin Binding Protein (RBP) 3-hydroxy-3-methylglutaryl-CoA 
reductase (HMGCR) 
Dolichyl Pyrophosphate Phosphatase-1 
(DOLPP1) 
Farnesyl Diphosphate Synthase (FDPS) 
Phosphatidylethanolamine N-
methyltransferase (PEMT) 
Lipin 1 (LPIN1) 
Choline Kinase (CHK) Peroxisomal 2,4-dienoyl-CoA Reductase
 
(DECR2) 
Very low density lipoprotein II 
(ApoVLDL-II) 
acyl-CoA synthetase long-chain family 
member 6 (ACSL6) 
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Table 2 Continued 
Genes With Significant Change 
 
Genes Without Significant Change 
Vitellogenin I (VTGI) Aldo-keto reductase family 1, member B1 
(AKR1B1) 
Liver Fatty Acid Binding Protein 
(FABP) 
Phosphatase and actin regulator 3 
(PHACTR3) 
Lipoprotein Lipase (LPL) SAM domain, SH3 domain and nuclear 
localisation signals protein 1 (SAMSN1) 
VLDL receptor (VLDLR) Ribosomal Protein S9 (RPS9) 
Cell death-inducing DFFA-like effector 
a (CIDEA) 
RNA polymerase III (DNA directed) 
polypeptide F, 39 kDa (POLR3F) 
Diazepam Binding Inhibitor (DBI) peptidylprolyl isomerase B (cyclophilin 
B) (PPIB) 
Malic enzyme 3 (ME3) Mitogen Activated Protein Kinase 12 
(MAPK12) 
Carboxy-terminal domain, RNA 
polymerase II, polypeptide A 
phosphatase, subunit 1 (CTDP1)  
Apolipoprotein E receptor 2 (LRP8) 
Forkhead Box A2 (FOX A2) Delta-6 fatty acyl desaturase (D6D) 
Insulin Induced Gene 1 (INSIG 1) Delta-5 fatty acyl desaturase (D5D) 
Fas associated factor family member 2 
(Ubxd8)   
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Estrogen changes the assembly of these unique VLDLy particles and also 
influences the transcription and stabilization of mRNA of specific gene transcripts to 
achieve desired effects.  The net consequence of estrogen induced changes in hepatic 
lipid and protein metabolism in birds is the production of small VLDL with distinctive 
changes in chemical composition. 
Estrogen appears to selectively alter gene expression to support massive 
increases in ApoB-LP assembly and secretion necessary to sustain yolk formation.  
Some genes necessary in yolk formation process are termed “estrogen dependent” while 
others are modulated by, but not dependent on, the hormone [26].  It has been shown in 
several studies that estrogen induces the synthesis of the egg specific proteins 
ApoVLDL-II and vitellogenin (VTG) [26-30].  Specific induction profiles for increases 
in protein synthesis following estrogen treatment differ for ApoB, ApoVLDL-II and the 
VTGs [26, 28, 31-33].  A study by Kirchgessner in 1987 illustrated that administration 
of estrogen produced a six fold increase in ApoB mRNA in the liver [34].  In a study by 
Capony and Williams, in response to estrogen treatment, ApoB synthesis increased 
sharply after a lag period of 1.5hrs, reached a maximum at 15-24hrs, and then returned 
to the control level [35]. 
Janero and Lane showed in a pulse-chase study that VLDL particle assembly 
requires about 30 minutes [36]. Using estrogen induced avian parenchymal liver cells, 
they determined that phospholipids were secreted in a biphasic pattern, the first secretion 
wave occurred 5-15 minutes into the chase, and the second wave after 30 minutes. 
12 
 
Appearance of radio-labeled TAGs occurred 20-25 minutes into the chase, and 
apolipoproteins were secreted after 30-35 of chase time [36].   
The yolk-specific proteins whose synthesis is induced by estrogen include VTG, 
ApoVLDL-II, and riboflavin binding protein (RBP); ApoVLDL-II is associated with 
VLDLy assembly, and all three are part of yolk assembly.  The gene expression of these 
three genes can be used to judge the efficacy of exogenous estrogen treatment.  The 
genes encoding ApoVLDL-II and VTGII exhibit estrogen-dependent nuclease 
hypersensitive sites, and an estrogen receptor-binding region has been identified on 
VTGII [34].   
Following induction of the synthesis of yolk-specific proteins, hepatic VLDLy 
apoprotein composition changes [37-39].  Instead of containing the usual ApoB plus 
about five other apoproteins, VLDLy contains predominantly ApoB plus one other 
apoprotein, ApoVLDL-II [37-39].  Competitive exclusion of other apoproteins from the 
surface of VLDLy by ApoVLDL-II is believed to be responsible for the simplicity of 
VLDLy‟s apoprotein content [38].  ApoVLDL-II synthesis accounts for 11% of soluble 
protein synthesized in the liver following a single estrogen injection [40].  Estrogen acts 
to stabilize the ApoVLDL-II mRNA, while estrogen removal selectively destabilizes the 
transcript [26, 33].  Estrogen‟s presence specifically stabilizes the mRNA by inducing 
the formation of a poly-adenosine tail, thus increasing the mRNA‟s half life and leading 
to an accumulation of ApoVLDL-II mRNA [41].  This is why VLDLy, through the 
action of ApoVLDL-II, continues to be produced approximately 24hrs after a single dose 
of estrogen [42].  Estrogen also appears to stimulate the rate of transcription of the 
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ApoVLDL-II gene prior to stimulation of lipid synthesis and ApoVLDL-II mRNA 
increases 100-fold within 3 hours of treatment [39].   
Estrogen induces ApoVLDL-II synthesis by directly inducing transcription of 
ApoVLDL-II mRNA [26].  ApoVLDL-II mRNA was shown to increase 12 fold after 
approximately fifty hours of estrogen exposure in rooster liver in a study done by Chan 
et al. [42]; VTG mRNA was shown to increase several thousand fold after 24hrs in a 
study done by Deeley et al. [43].     
 ApoVLDL-II contains two 82-amino acid residues linked by a single disulfide 
bond at residue 76 [44].  ApoVLDL-II is unique to avian species.  ApoVLDL-II is found 
in the chicken as a homodimer, with each subunit being 9 kDa [45].  Conversely, in 
other avian species like the quail, ApoVLDL-II is found as a monomer.  Both 
monomeric and dimeric forms inhibit LPL [46].  The typical metabolic course of TAG-
rich VLDL in non-egg laying states ends in TAG hydrolysis by the enzyme LPL [47].  
Hepatic VLDL assembly processes are retooled to form VLDLy in response to an 
estrogen dependent transcription program.  These VLDLy are unique among TAG rich 
lipoproteins as they resist hydrolysis by LPL [12].  The presence of ApoVLDL-II in 
VLDLy is believed to mediate the reduction in this lipoprotein‟s diameter [12], possibly 
by competitively excluding other exchangeable apoproteins, such as ApoC-II, from the 
surface of VLDLy causing LPL resistance [38]. 
  VTGs are ancient, very high density lipoproteins, responsible for lipid transport 
and protein storage that are not physically associated with VLDLy, but play a role in 
yolk formation [48].  Deeley showed that VTG is the only phosphoprotein present in the 
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plasma of the estrogen treated rooster [27].  There are three VTGs, one major (VTGII) 
and two minor (VTGI and VTGIII) protein isoforms.   Avian VTG is composed of two 
polypeptides, each having a molecular weight of 240,000, and is actually a cryptic 
peptide that becomes the egg yolk phosphoproteins lipovitellin and two phosvitins, one 
with a molecular weight of 28,000 and the other 34,000 [27].  In the yolk, the products 
form granules, which also contain lipids and metals, including zinc, which were carried 
into the yolk with the VTG [49].   
For oviparous species, vitamin delivery to the oocyte is a special challenge which 
must occur prior to egg fertilization and laying [50].  Avian RBP is a 29 kDa 
phosphoglycoprotein, which is a necessary component of chicken eggs; it supplies the 
oocyte and egg white with the riboflavin necessary to sustain embryonic development 
[50].  A study by Mac Lachlan showed that RBP associates with VTG in serum, 
“piggybacking” with VTG into the growing oocyte through the interaction of VTG with 
the 95 kDa VLDL/VTG receptor [50].  
The vital apolipoprotein in VLDLy particles is ApoB100, which is an amphipathic 
protein that is synthesized in the liver as a 4536-amino acid polypeptide [5].  It has five 
secondary structural domains and contains an oddly large number of cysteine residues in 
disulfide linkages which are believed to be essential for VLDL assembly [5].  ApoB100 
serves as the ligand for the ApoB receptor.  The receptor binding domain of ApoB100 
includes a cluster of positively-charged residues at amino acids 3359-3367 [5].   
ApoB100 is a positive risk factor in the development of atherosclerosis in humans 
and it is present in the arterial wall in atherosclerotic lesions [2].  A study by Williams 
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showed that ApoB correlated significantly (p<0.05) inversely with HDL cholesterol, 
LDL size, and insulin sensitivity, and positively with body mass index, waist 
circumference, TG, DBP, systolic blood pressure, 2-hour and fasting glucose and insulin 
levels, CRP, fibrinogen, PAI-1, and both common and internal carotid artery intima-
media thicknesses (IMTs); this makes ApoB concentration an important risk factor for 
developing heart disease [51].   
The ApoB100 protein remains on the ApoB-LP molecule from synthesis to 
degradation because ApoB100 does not undergo exchange reactions [2].  It is insoluble, 
susceptible to degradation, oxidative cleavage, and aggregation [2].  The quality and 
amounts of VLDLy that are assembled and secreted are controlled at several points 
within the apoB assembly process [13, 52].  The first hypothetical sorting site is during 
translation and translocation of a growing ApoB peptide chain [12].  ApoB100 that is not 
translocated to the lumen of the RER is then included into the outer leaflet of the ER 
where it is eventually degraded by intracellular proteases [12].  Sorting of ApoB100  at 
this step controls the amount of ApoB100 available for VLDL assembly [12].  The second 
sorting step follows translocation of nascent ApoB100 and  depends on neutral lipid 
availability for lipoprotein core formation [12].  The ApoB100, at this second sorting site, 
must achieve sufficient TAG and cholesterol ester to gain a buoyant density of 1.0063 
g/mL [53].  If this does not occur, then the particle is termed “misfolded” with regard to 
ApoB conformation; thus, it is sorted for degradation [52].  A final sorting step occurs 
immediately post secretion at the surface of the hepatocyte, where overly small VLDL 
are endocytosed by the LDL receptor [54]. 
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A lipoprotein unique to egg-laying species, VLDLy has been shown to have a 
complex assembly process that produces a specialized particle that is vital to the growing 
bird.  It is useful to experimentation that VLDLy depend on estrogen exposure for 
specific assembly.  This fact allows for induced VLDLy assembly to occur within an 
experimental environment with application of exogenous estrogen.    
Animal Model Selection 
Of particular interest is the physiologic difference between egg laying organisms 
and mammals, whose offspring are of placental origin.  It is possible to take advantage 
of the developmental strategy of birds to study very low density lipoproteins (VLDL).  
In humans, ApoB-LP can contain one of two isoforms of ApoB: ApoB100 and ApoB48; 
this is believed to be the same in rats and rabbits [55, 56].  Mouse and hamster models 
also contain both ApoB100 and ApoB48 [57].  ApoB48 is a product of ApoB mRNA 
editing by the enzyme APOBEC-1, expressed in the human small intestine [55].  This 
editing changes a glutamine codon to a stop codon, thus creating a shorter transcript that 
encodes a protein that has a molecular weight approximately 48% of an apolipoprotein.  
Human liver does not edit ApoB because it does not express APOBEC-1 [55].   
Avian species do not edit ApoB100 mRNA as do mammals; their intestines, as 
well as livers, produce full-length ApoB100 [1].  In contrast, isolated rat liver and rat 
hepatocytes in culture produce both ApoB48 and ApoB100, making them less useful for an 
ApoB100 centered study [58].  Also, assembly processes may not be equivalent between 
rodent and avian species.  The chicken, Gallus gallus, produces ApoB100 in the kidney, 
intestine, and liver, as shown through in a study by Blue, where in vitro pulse labeled 
17 
 
tissues were measured in a double antibody procedure [59].  Only ApoB100 synthesis in 
liver is increased by elevation of plasma estrogen, making the chicken a useful model 
organism for the selective study of ApoB100.   
Estrogen treatment of male birds mimics the effects of female sexual maturation 
and increases ApoB-LP assembly in male birds fourfold 16hrs after injection [60].  In 
one study, 60 mg of 17-β estradiol dissolved in 1.5 ml sodium benzoate was needed for 
maximal effectiveness in inducing hepatic synthesis of VLDL in 2.0-4.5 kg White 
Leghorn roosters [60].  Estrogen induction of male chicks is one of the techniques 
applied in this thesis. 
In mammals, a constant supply of ApoB100 supports VLDL assembly due to the 
constitutive expression of the gene [61, 62].  The fixed rate of gene expression in 
mammals demanded that non-transcriptional mechanisms be used to explain changes in 
ApoB100 secretion rates with various treatments [12]. 
Genes Thought to be Involved in ApoB-LP Assembly 
Genes shown to be critical for VLDLy formation in various knockout models are 
ApoB [63], MTP [20], and DGAT-2 [64], among others.  ApoB is a gene that is 
responsible for the ApoB100 protein; ApoB100 is a necessary structural and functional part 
of VLDLy [1].  MTP is an ER luminal protein with lipid transfer activity [1].  It is 
thought that MTP facilitates regulated transfer of lipids and folding of ApoB as it exits 
the ribosome and enters the ER lumen [23].  Diacylgylcerol phosphate acyl transferase 2 
(DGAT-2, E.C. 2.3.1) is an enzyme that catalyzes the acylation of diacylglycerol, which 
is necessary for the formation of TAG [65].   
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Two other genes expected to supply the fatty acids required for the massive 
demand for acylglycerol lipid components following estrogen mediated induction of 
VLDLy assembly and secretion were fatty acid synthase (FAS, E.C. 2.3.1.85) and acetyl 
Co-A carboxylase (ACC, E.C. 6.4.1.2).  Fatty acid synthase was selected as it is a key 
enzyme in fatty acid synthesis, catalyzing the synthesis of long chain fatty acids through 
the condensation of acetyl-CoA and malonyl-CoA in a complex seven-step reaction [66].  
Acetyl Co-A carboxylase is the rate limiting enzyme in fatty acid synthesis; it catalyses 
the carboxylation of acetyl-CoA to malonyl-CoA.  Malonyl-CoA synthesized by ACC is 
a critical regulator of lipid metabolism, and plays roles in the regulation of oxidation and 
synthesis of fatty acids [67].   
When cells are exposed to stressful conditions, including heat shock, a small 
number of highly conserved proteins, known as heat shock proteins (HSP), must be 
quickly expressed as part of an important survival response.  Heat shock protein, 
particularly HSP-70, can repair proteins that unfold, misfold or aggregate upon stress, 
assisting in the recovery of the cell [68], and is believed to be a key chaperone in 
ApoB100 folding [69].  HSP-70 may play an important role in cell survival by 
interfering with apoptotic programs [70].  Overexpression of HSP-70 during heat shock 
may protect cells from stress-induced apoptosis preventing the activation of pro-caspases 
9 and 3 [70].  VLDL assembly requires several cell process that work in a synchronized 
fashion.  This puts stress on the cell and calls HSPs into play to elicit a survival 
response.   
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 Malic enzyme (E.C. 1.1.1.40) catalyzes the oxidative decarboxylation of malate 
to pyruvate and CO2, simultaneously generating NADPH from NADP+ [71].  In the 
avian liver, most of the NADPH used by FAS to catalyze the synthesis of the fatty acid 
palmitate (16:0) is generated by malic enzyme [72].   
Circadian Rhythms  
Circadian rhythms are known patterns of biochemical, physiological, or 
behavioral processes that occur in a cyclic pattern.  Circadian rhythms are endogenous to 
an organism and can be adjusted by external cues such as the environment.  The primary 
environmental cue seen in nature is sunlight.  It is known that genes related to lipid 
synthesis will vary in a circadian manner [73, 74].  Due to this fact, all animals used in 
this study were sacrificed at the same time of day (approximately 17:00) and at the same 
nutritional status to minimize circadian variations between the animals.  
Much of circadian science is based on the concept of zeitgeber, meaning “time 
giver” in German.  Zeitgeber is any exogenous cue that synchronizes an organism‟s 
endogenous clock to earth‟s light/dark cycles.  Light is the strongest zeitgeber for both 
plants and animals.  
 There are two locations of organs and tissues, central and peripheral, which 
control circadian rhythms; these tissues are termed oscillators.  In avian species, the 
central part of the circadian system is made up of the suprachiasmatic nucleus, retina, 
and the pineal gland [75].  Peripheral oscillators are present in tissues including the heart 
and liver [76].  These central and peripheral oscillators interconnect to synchronize 
phase relationships inside the organism to the external environment [77]. 
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Transcriptional Profiling 
Transcriptional profiling is a method to measure gene expression within a 
controlled setting, such as disease vs. non-disease state; it can be done by using various 
techniques that measure the levels of transcription in a tissue of interest.  The most 
common method of transcriptional profiling is through microarray.  Transcriptional 
profiling is useful because it can give an overall “snapshot” of what is occurring at the 
cell at one point in time.  A limitation is that annotation of the profiled genes must be 
adequate for results and conclusions from transcriptional profiling to be made. 
Prior to gene transcriptional profiling, messenger RNA (mRNA) that are gene 
transcripts must be extracted from tissue and its quality assessed.  This extract will 
contain transcripts of both “genes of interest” that may have been identified by some 
prior knowledge, as well transcripts for which the experimentor has no prior 
expectations.  Microarray studies are a powerful approach to discover new genes of 
interest.  An estimate of the quality of the initial transcript collection extracted from the 
tissue typically involves both spectrophotometric and electrophoretic analyses. 
Spectrophotometrically, mRNA‟s absorbance should be measured at 230 nm, 260 
nm, and 280 nm.  High quality mRNA extracts possess specific (optimal) ratios of 
optical absorbance at certain wavelengths, namely 260/280 and 260/230.  Both ratios 
give information on the quality of the mRNA.  The 260/280 value estimates the level of 
protein contamination in the mRNA sample; the ideal range of this value is 1.7-2.0.  The 
260/230 value estimates the level of organic contamination of the mRNA, and the 
desired range of this ratio is 2.0-2.3.  Solutions of extracted mRNA that have optimal 
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values for these two ratios are assumed to be relatively free of protein and other organic 
contaminants and suitable for use in transcriptional profiling studies.   
An additional method to judge the quality of the mRNA is the use of agarose gel 
electrophoresis.  This is a method to separate nucleic acids by length.  An electric field is 
applied to the gel to move the negatively charged nucleic acids through the gel.  Shorter 
nucleic acids migrate through the agarose faster than longer nucleic acids due to the 
increased ease of transport of smaller particles through the pores of the gel.  Intercalation 
of ethidium bromide between RNA bases provides a means of band identification.  High 
quality RNA should have one bright, distinct band at 18S and another at 28S.  Any 
samples in which bands were smeared or that did not have bright bands must be purified 
or re-extracted.   
To validate outcomes of transcriptional profiling through microarray, a second, 
independent method to assess changes in gene expression should be applied to sample 
mRNA.  Quantitative real time polymerase chain reaction (q-RTPCR) is one such 
independent method.  In q-RTPCR, a so-called “housekeeping gene”, that is, a gene that 
is expressed at the same level at all times in each sample are measured along with genes 
of interest.  The genes β-actin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 
E.C. 1.2.1.12) are often used as housekeeping genes to normalize each gene of interest.  
Comparing the level of expression of the housekeeping gene to the level of expression of 
the gene of interest gives the level of expression of the gene of interest relative to a 
constant value.  In this way, changes in gene expression can be estimated. 
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The recent development of microarray technology, along with specific arrays for 
various species including the chicken, has allowed for extensive analysis of genetic 
markers and pathways.  A large collection of EST‟s enabled the creation of high density 
microarrays [78].  Tissue specific, as well as global, microarrays have been created for 
the chicken.  These arrays include a 3,011 lymphocyte array [79], a 3,072 intestinal array 
[80], an 11K heart specific array [81], a 14,718 macrophage specific array [82], a 13K 
cDNA chicken genome array [83], a 5K immune related array [83, 84], a 20K long oligo 
chicken genome array [85], and a 33K Affymetrix chicken genome array [86].  
There are several classes of microarray technology.  Affymetrix was the pioneer 
in this field with the GeneChip platform.  GeneChip technology is based on short, 
single-stranded DNA segments, or oligonucleotides, that are built to order by chemical 
synthesis [87].  High density arrays are constructed using light directed DNA synthesis, 
namely photolithography and solid-phase DNA synthesis [87].  The photolithographic 
technique uses a silicon substrate onto which photochemically removable protecting 
groups are attached [88].  Light is directed through a photolithographic mask to produce 
specific photodeprotection on the chip surface [88].  Specific deoxynucleosides are then 
incubated with the surface and chemical coupling to the surface occurs; using new masks 
the process is repeated until the chip of 25-mer probes is complete [88].  Advantages to 
the GeneChip are in silico design and probe redundancy, present because multiple 
independent oligonucleotides are designed to hybridize to different regions of the same 
RNA [88].   
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Agilent (Palo Alto, CA, US) uses inkjet printing through phosphoramidite 
((RO)2PNR2) chemistry to carry out in situ synthesis of 60-mer oligonucleotide probes 
on or near the surface of the microarray slide [89].  In a study by Hughes, it was found 
that 60-mer arrays can reliably detect transcript ratios at one copy per cell in complex 
biological samples, and that these arrays are compatible with different sample 
amplification and labeling techniques [89].  An advantage to Agilent technology is that 
Agilent probes are 60-mer oligonucleotides, while GeneChip probes are only 25, making 
the Agilent probes more site-specific.  In addition, the Agilent probes are able to reliably 
detect transcript ratios of one copy per cell in complex samples.   
The Agilent 60-mer oligonucleotide 44K chicken array was developed in 2008 
by a group at Texas A&M University [90]. The 44K array consists of 42,034 features, or 
individual spots on the array which hybridize to a specific oligonucleotide sequence, 
based on the whole chicken genome sequence plus 1264 positive control features and 
153 negative control features [90].   
 The development of microarray technology has opened countless doors allowing 
whole-genome research.  These highly specific slides also allow the researcher to create 
a specialized array, focus on a set of particular genes or encompassing an organism‟s 
genetic makeup.  With this technology, transcriptional profiling is quickly and easily 
accomplished.  The custom 44K Agilent array was utilized for the current study, as it is 
based upon the chicken‟s whole genome sequence. 
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Bioinformatic Analysis of Transcription Data 
 A series of basic steps are followed to process microarray derived data for 
transcriptional profiling:  1. Normalize the raw data outputs using technique-specific 
software   2. Remove any background technique generated noise (a form of systematic 
error)  3. Normalize the data to determine significance of individual data points  4. 
Carry out specialized statistical methods to answer specific questions  5. Use literature 
and online databases to determine the identity or homology of specific gene sequences if 
annotation is unavailable.  Annotation is the process by which important pieces of 
information about a particular gene‟s raw gene sequence or gene product function are 
added to a database.  This includes describing different sections of the raw gene 
sequence as protein-coding, nonfunctional, or regulatory, as well as providing links to 
publications that describe gene product function, regulation or similarity to other coding 
regions. 
To determine if results are statistically meaningful, and the gene of interest is 
present, significance can be assessed by using the statistical formula and significance 
boundaries of the researcher‟s choice.  In this particular study, transcription data was 
analyzed using Lowess normalization and a significance level of p<0.05 was chosen.  
Lowess normalization allows the researcher to correct for background signal, and 
determine that a gene is expressed at a level above or below that background signal.  
After statistically meaningful results are determined, the researcher is able to use the 
genes expressed differently from background signal to cluster genes and do further gene 
identification, annotation, analysis.   
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There are countless online databases that are useful tools for analyzing nucleotide 
sequence for similarity and identity, finding gene localization, and determining gene 
pathways, among others.  NCBI BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) can 
identify similarities in gene sequences with great speed [91].  NCBI also has a feature 
termed Homologene which is an automated system for detecting homologs among the 
annotated genes of several completely sequenced eukaryotic genomes, including those of 
chickens, mice, and humans [91].  
The Database for Annotation, Visualization and Integrated Discovery (DAVID) 
is a database used for large scale functional annotation of identified genes [92, 93].  It 
utilizes a gene list and gene background, both entered by the user.  The program then 
uses available online resources, including the Gene Ontology project, to compare the 
“interesting” gene list to the background.  According to DAVID, a “good” gene list 
contains many important markers, including containing a reasonable number of genes 
(100-2,000), and passing the statistical threshold for selection in the particular 
experiment being done [92, 93].  For example, in the estrogen induction experiment, the 
statistical threshold for inclusion of a particular gene‟s outcome in a DAVID analysis 
was a signal to noise ratio (SNR) greater than three at a minimum of one sampling point, 
and a significance of p<0.05 after Lowess normalization [94].  Importantly, in 
experiments where two fluorescent dyes (red and green) are used, intensity-dependent 
variation in dye bias may introduce spurious variations in the collected data. Lowess 
normalization merges two-color data, applying a smoothing adjustment that removes 
such variation [95].  This correction is “Step2” in transcriptional profiling data analysis 
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for this specific technique.  After this process the transcripts for which sufficient 
statistical confidence exists to declare the gene “present” in the sample will have been 
identified.  This dataset can be subjected to further statistical analysis to determine 
whether experimental treatments alter the relative amounts of each transcript that is 
present.   
Gene Ontology (GO) is a collaborative effort to address the need for consistent 
descriptions of gene products in different databases [96].  Within GO, three structured, 
controlled “vocabularies” (ontologies) describe gene products in a species-independent 
manner [96].  The three ontologies are molecular function, cellular component, and 
biological process.  Cellular component describes a component of the cell that is part of 
some larger object.  Molecular function represents activities rather than the entities 
(molecules or complexes) that perform the actions.  They do not specify where or when, 
or in what context, the action takes place.  Biological process describes a series of events 
accomplished by one or more ordered assemblies of molecular functions [96].  These 
events must have more than one distinct step.  Determining biological process data, 
including signal transduction and specific gene/protein interactions is a long term 
objective of this work.  
GeneCards is an easy to use, searchable online database that integrates 
information from several online databases onto one page for each gene.  The data 
presented on the GeneCards site is extracted or linked to over 80 external databases and 
digital sources [97].  The data for each available gene includes function, sequences, 
orthologs, variants, aliases, and pathways, among many other pieces of information. 
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In all, transcriptional analysis can give a rich dataset of significant values.  
Further statistical analysis can give interesting clusters and patterns of data, and are 
invaluable to a whole-genome array experiment.  Online databases sponsored by the 
government, institutes of higher education, and non-profit groups lend insight to genes 
whose function or homology is unknown, further enriching the experiment outcomes. 
Conclusion 
In conclusion, the assembly of VLDL (and VLDLy) is a complex process that is 
incompletely understood.  The chicken has frequently been used for studies of VLDL 
assembly since massive increases in plasma VLDL occur in response to exogenous 
estrogens in the rooster or with the onset of egg laying in the hen [60].  In avian species, 
the liver is the main site of de novo fatty acid synthesis, accounting for 95% in young 
chicks [98-100].   
 The current study hypothesized that estrogen induction will selectively alter 
hepatic gene expression to facilitate VLDLy assembly and secretion.  An underlying 
assumption in this study was that the same processes used to assemble VLDL operate 
during VLDLy assembly, albeit perhaps modified to accommodate the inclusion of 
ApoVLDL-II into VLDLy structure.  We further hypothesized that by measuring 
changes in hepatic gene expression in relation to time following estrogen exposure  
requisite changes in cellular processes to “retool” VLDL assembly for VLDLy 
assembly, including a general up regulation of all gene products required for ApoB-LP 
assembly, that all components of that assembly process might be identified.   
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 Objectives of this study included: using the estrogen induced chick model to 
identify which genes are expressed before and at each of five time points following a 
maximally stimulating estrogen dose, characterizing identified genes using publically 
available databases, correlating changes in gene expression with phenotypic changes in 
plasma lipoproteins and selected tissue weights, determining whether anticipated 
changes in ApoB gene expression could be used to identify other genes associated with 
VLDLy assembly processes.   
 It is hoped that this project will lead to a better understanding of the assembly of 
VLDLy particles.  This study is a first-pass analysis of the feasibility of using gene 
transcription assays to characterize the assembly of a VLDLy.  Information gained on 
gene expression patterns and experimental techniques from this project will benefit 
future gene-centric projects focusing on particle assembly. 
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CHAPTER II 
MATERIALS AND METHODS 
 
Animal Subjects: Experiment 1 
A total of twenty-four, 7-10 day old chicks were studied in the microarray 
survey.  The chicks were maintained at the Texas A&M University Poultry Research and 
Teaching Facility in accordance with AUP #2009-245.  The chicks were fed a 
nutritionally adequate non-purified grower ration (Table 3) in routine use at the TAMU 
Poultry Research and Teaching Facility.   
Animal Subjects: Experiment 2 
To compare a natural estrogen cycle to the artificially induced model employed 
in Experiment 1, twelve female Lohmann birds were studied during the pullet/layer 
transition.  Four pre-production pullets (15wk 4d), four immediate pre-production hens 
(16wk 3d), and four egg-laying hens (26wk 1d) were used.  The hens were maintained at 
the Texas A&M University Poultry Research and Teaching Facility.  Pullets were 
provided the same non-purified grower ration (Table 3) until transfer to a nutritionally 
adequate layer ration at 16 weeks of age (Table 4).  This feed is in routine use at the 
TAMU Poultry Research and Teaching Facility and is provided for ad-libitum 
consumption according to AUP#2009-245.  The hens were not fasted prior to tissue 
sampling.   
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Table 3: Chick grower ration. 
Ingredient  
Corn (%) 64.21 
Soybean Meal (%) 23.60 
Limestone (%) 10.09 
Biofos (%) 1.17 
Salt (%) 0.46 
Vitamins Mix (%) 0.25 
DL-MET98 (%) 0.17 
Trace Minerals Mix (%) 0.05 
Calculated composition  
Protein (%) 2.319 
Calcium (%) -0.027 
AV Phosphate (%) 0.829 
TSAA (%) 2.544 
Sodium (%) -0.052 
ME (kcal/kg) 2733.21 
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Table 4. Composition of the basal diet - pre lay. 
Ingredient  
Corn (%) 70.3 
Soybean Meal (%) 22.7 
Limestone (%) 5.29 
Biofos (%) 1.02 
Salt (%) 0.38 
Vitamins Mix (%) 0.25 
DL-MET98 (%) 0.05 
Trace Minerals Mix (%)  
Calculated composition 2.974 
Protein (%) -0.037 
Calcium (%) 0.818 
AV Phosphate (%) -0.0618 
TSAA (%) 2909.22 
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Treatment and Sampling Protocol: Experiment 1 
The experiment was conducted in a way that produced different lengths of 
exposure to exogenous estrogen, but tissue was collected at the same “clock hour” for all 
birds (Table 5).  Four chicks were injected with 10 mg/kg diethylstilbesterol in extra 
light olive oil (Star, Borges USA, Fresno, CA) at the start of experimentation and at four 
time points following [101].   
Injections occurred 12 hours, 18 hours, 21 hours, and 22.5 hours before liver 
harvest (Figure 2).  Four chicks served as vehicle-injected controls and were killed at 
time zero.  This scheme generated four chicks that were exposed to estrogen for each of 
the following lengths of time: 0, 1.5, 3, 6, 12, 24 hours.  Dosing was timed so that all 
birds were killed at constant clock hour, specifically 17:30h.   
This component of the experimental design aimed to remove any changes in gene 
expression due to circadian rhythms.  Birds were anesthetized in a chamber filled with 
4% isoflurane (IsoFlo, Abbott Laboratories, Abbott Park, Illinois) and 96% oxygen 
(Praxair, College Station, TX).  Birds were checked to ensure full anesthetization had 
occurred by observing animal reaction to an abdominal skin pinch.  After full 
anesthetization occurred, the bird was removed from the chamber and transferred to a 
prepared surgical table; a face mask was attached to the bird to provide continued 
sedation.  Birds were exsanguinated by cardiac puncture; their livers were removed 
rapidly and immediately frozen on dry ice in between two pieces of foil.  After freezing 
the livers were sealed between the foil pieces and placed into a -80C freezer.  
Precaution was taken with the foil to avoid any contamination of the foil prior to use and 
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Table 5. Estrogen induction and sacrifice time course. 
Length of Estrogen Exposure (hrs) 
 
Time of Estrogen Injection 
 
Time of Sacrifice 
 
24.0 Day 1  17:30 Day 2  17:30 
12.0 Day 2    5:30 Day 2  17:30 
6.0 Day 2  11:30 Day 2  17:30 
3.0 Day 2  14:30 Day 2  17:30 
1.5 Day 2  16:00 Day 2  17:30 
0.0 Day 2  17:30 Day 2  17:30 
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Figure 2. Estrogen induction flowchart. 
  
Day 1 – 17:30 
Inject 4 chicks 
Day 2 – 05:30 
Inject 4 chicks 
Day 2 – 11:30 
Inject 4 chicks 
Day 2 – 14:30 
Inject 4 chicks 
Day 2 – 16:00 
Inject 4 chicks 
Day 2 – 17:30 
Inject 4 chicks 
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to avoid the foil becoming frozen in folds of the livers during freezing.   
Treatment and Sampling Protocol: Experiment 2 
Hens received an electric current to the temple using a SKVS electric stunning 
knife (Pickwick-Knase, Eden Prairie, MN), and their throats were punctured.  Blood was 
collected from the neck and stored on ice in 10 mL Vacutainer (Beckton Dickinson, 
Franklin Lakes, NJ) collection tubes.  Livers were removed, weighed, and immediately 
frozen on dry ice as described for Experiment 1.  The hen‟s body weight, liver weight, 
pelvic width at midpoint of the ischium, ovary weight, oviduct weight, ovarian status, 
and follicle presence and weight were recorded  
Biochemical Measurements: Experiment 2 
A portion of the processed plasma was sent to the Texas Veterinary Medical 
Diagnostic Laboratory on the campus of Texas A&M University for 17β-Estradiol 
quantification. Estrogens were extracted from plasma using 1.0 mL of dichloromethane 
and  0.5 mL plasma sample.  After extraction, the sample was dried under a stream of 
nitrogen and rehydrated with phosphate buffered saline; 200 µl was used in duplicate for 
radioimmunoassay.  The Siemens Estradiol Double Antibody Kit #KE2D1 (Siemens, 
Munich, Germany) was used for analysis.  The sample was incubated with antibody 
supplied with the kit for 2hrs, and then incubated for 1hr with the tracer supplied with 
the kit.  Finally, the antibody bound fraction was precipitated and counted using a 
Genesys 5000 gamma counter Model LTI505 (Laboratory Technologies, Inc., Maple 
Park, IL).  
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Lipoprotein Diameter Measurements: Experiment 2 
 Reduction in VLDL particle diameter is characteristic of VLDLy formation. In 
order to determine whether patterns of gene expression coincided with this physiological 
marker, VLDL diameters were determined in intact female chickens undergoing the 
pullet/layer transition. Venous blood samples were placed in a pre-chilled Sorvall RT-
6000B (Thermo Fisher Scientific Inc., Asheville, NC) tabletop refrigerated centrifuge 
and spun for 30 minutes.  The plasma was removed from the tubes and transferred to 
collection tubes containing EDTA.  One milliliter of plasma was put into each 
UltraClear centrifuge tube catalog # 344624 (Beckman Coulter, Inc., Brea, CA).  Five 
milliliters of d=1.0255 solution was added to total 6 mL per tube with a final density of 
1.022 g/mL.  The tubes were placed in a Beckman TFT 44.5 rotor (Beckman Coulter, 
Inc., Brea, CA) and subjected to ultracentrifugation at 14˚ C at a speed of 40,000 RPM 
for 18 hours with a maximum temperature of 25˚ C using a Beckman L8-70M 
Ultracentrifuge (Beckman Coulter, Inc., Brea, CA).    
 After centrifugation was complete, the diameters of lipoproteins recovered from 
the floating lipid layer were measured using a Nanotrac NPA 250 (Microtrac software 
version 10.5, Clearwater, FL).  Each sample was analyzed in triplicate with a 
measurement time of 60 seconds for individual measurements, with the following 
parameters: particle refractive index=1.46, transparent/irregular particle, density=0.98, 
fluid refractive index=1.34, high temperature=26C, viscosity=0.889, low 
temperature=20C, fluid viscosity=1.002, analysis option=high sensitivity, 
perspective=number, progression=geometric 8 root. 
37 
 
Molecular Measurements: Experiment 1 
RNA was extracted from all livers using the Ribopure kit using approximately 
10-15 mg of tissue and according to standard kit protocol (Ambion, Inc., Foster City, 
CA).  Tissues were homogenized using a VWR VDI 12 SI homogenizer (VWR 
International, Radnor, PA).  The concentration (ng/uL), level of organic contamination 
(260/230 ratio) and level of protein contamination (260/280 ratio) of each sample was 
determined using a NanoDrop spectrophotometer (Thermo Scientific, Waltham, MA).  
Samples with ratios outside of the desired range (1.7-2.0 for 260/280 and 2.0-2.3 for 
260/230) were concentrated using Ambion‟s (Ambion, Inc., Foster City, CA) sodium 
acetate precipitation of small nucleic acids protocol by combining the total RNA with 
0.1 vol 3.0 M sodium acetate (Ambion, Inc., Foster City, CA), 3 vol 100% ethanol 
(KOPTEK, King of Prussia, PA), and 3 vol of 70 µg glycogen, Lot #411291 (Illumina, 
Inc., San Diego, CA).  Mixtures were then placed in a -80°C freezer for fifteen hours.  
The samples were centrifuged at 14,000 rpm at 4˚C for fifteen minutes.  The supernatant 
was removed and 200 µL of 75% ethanol was added to the pellet.  The pellet and 75% 
ethanol were centrifuged for five minutes at 8,000 rpm at 4˚C.  The supernatant was 
carefully removed from the tube, and the pellet was allowed to air dry for five minutes in 
the same tube, on ice, with the tube opening parallel to the surface of the ice.  The 
samples were then diluted to 800 ng RNA/µL in RNAse free water to a total volume of 
40 µL.  To do this, the sample concentration was measured using a NanoDrop 
spectrophotometer (Thermo Scientific, Waltham, MA).  The formula (800 
ng/µL)*(40µL)/(concentration in ng/µL) was used to determine the volume of RNA to 
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add to make 40 µL at a final concentration of 800 ng/µL.  The amount of RNAse free 
water to add was determined by subtracting the volume of RNA stock solution added, 
using the above calculation, from 40 µL.  The resulting samples were stored at -80˚C 
until used.   
Additional confidence in the integrity of the RNA was sought through the use of 
denaturing agarose gel electrophoresis.  100 mL of 1% denaturing agarose gel was made 
by combining 1.0 g agarose (Bio-Rad, Hercules, CA) with 90 mL of RNase free water in 
an Erlenmeyer flask.  The flask was heated in the microwave until the agarose was 
melted, and then placed in a 60C water bath until flask temperature was equilibrated.  
10 mL of NorthernMAX 10X running buffer (Ambion, Inc., Foster City, CA), and 1.5 
µL of 10 mg/mL ethidium bromide (Promega, Madison, WI) were added to the flask and 
swirled to mix.  The agarose solution was poured into an RNase free BioRad Sub-Cell 
GT System Horizontal Gel Electrophoresis System with a 15x15 cm gel tray size (Bio-
Rad, Hercules, CA).  After the gel hardened, 1X MOPS running buffer (Lonza, Basel, 
Switzerland) was added to cover the gel.  A 1.0 µg aliquot of each sample was combined 
with 2.5X the sample volume of NorthernMAX formaldehyde load dye (Ambion, Inc., 
Foster City, CA) in a 0.2 µL tube.  Prepared sample tubes were thoroughly mixed with a 
VortexGenie (Scientific Industries, Bohemia, New York) and incubated for 10 minutes 
at 65C.  Tubes were removed from the incubation and placed on ice for 5 minutes.  
Samples were loaded into each well and run at 140 volts for 25 minutes.  Bands were 
visualized using a Kodak EDAS 290 Electrophoresis Documentation and Analysis 
System (Kodak, Rochester, NY).  High quality RNA should have one bright, distinct 
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band at 18S and another at 28S.  Intercalation of ethidium bromide between RNA bases 
provides a means of band identification.  Any samples in which bands were smeared or 
that did not have bright bands were purified or re-extracted.  All previously used 
techniques to determine concentration and purity were applied to these subsequent 
samples. 
Highly concentrated RNA samples with clear bands on a denaturing gel and 
acceptable 260/280 and 260/230 ratios were labeled and hybridized to the 44K Agilent 
chicken microarray (Agilent Technologies, Inc., Santa Clara, CA).  Sample labeling was 
accomplished using a dual-dye system, shown in Table 6.   
The Agilent 44K chicken array is a two-color microarray where two different 
cDNA samples, one labeled with one color dye, and one labeled with another color, are 
hybridized to a single probe.  Dual dye systems function to eliminate dye bias, as half 
the control samples on each slide were labeled with cyanine 3 (Cy3) and the other half of 
the control samples labeled with cyanine 5 (Cy5).  The concentration and purity of the 
labeled samples was again measured using a NanoDrop spectrophotometer (Thermo 
Scientific, Waltham, MA) prior to hybridization to a Gallus gallus 44K Agilent array 
containing 43,803 probes [90].  RNA isolated from samples taken at time points 24, 12, 
6, 3, and 1.5 was hybridized with one zero time point control sample. Under this scheme, 
four replicates of the entire time course were generated. 
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Table 6: Microarray dual dye scheme. 
Slide # Array # 
Cy5 Labeled 
Sample # 
Time Point (hr) 
Cy3 Labeled 
Sample # 
Time Point (hr) 
1 
1 6 1.5 h 2 0 
2 7 0 18 1.5 h 
3 34800 1.5 h 9 0 
4 34776 0 34783 1.5 h 
2 
1 11 3.0 h 2 0 
2 7 0 13 3.0 h 
3 34788 3.0 h 9 0 
4 34776 0 34789 3.0 h 
3 
1 5 6.0 h 2 0 
2 7 0 10 6.0 h 
3 34780 6.0 h 9 0 
4 34776 0 34790 6.0 h 
4 
1 3 12.0 h 2 0 
2 7 0 4 12.0 h 
3 34794 12.0 h 9 0 
4 34776 0 34796 12.0 h 
5 
1 8 24.0 h 2 0 
2 7 0 12 24.0 h 
3 34787 24.0 h 9 0 
4 34776 0 34778 24.0 h 
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The slides were incubated at 65C for seventeen hours in Agilent's microarray 
hybridization chambers. After hybridization, arrays were washed according to the 
Agilent Two-Color Microarray-Based Gene Expression Analysis Protocol Version 5.7, 
Manual # G4140-90051 (Agilent Technologies, Inc., Santa Clara, CA).  Labeling, 
hybridization, and washing procedures were all done following Agilent‟s Two-Color 
Microarray-Based Gene Expression Analysis Protocol Version 5.7, Manual # G4140-
90051 (Agilent Technologies, Inc., Santa Clara, CA).   
A 1.0 ug aliquot of total RNA was used to synthesize first-strand cDNA using the 
Thermoscript™ RT-PCR system (Invitrogen, Carlsbad, CA), and utilizing the random 
hexamers provided in the kit in a reaction volume of 20 μL. This reaction was done in a 
MJ Research PTC-200 Peltier Thermal Cycler (Bio-Rad Laboratories, Inc., Hercules, 
CA) with the following program: 94C for 15 min, 30 cycles of 64C for 30 sec, 59C 
for 30 sec, and 72C for 30 sec, and 64C for 15 min.  The resulting cDNA was used to 
amplify GAPDH primers (Sense-5‟-GTGAGTCCACTGGTGTCTTCAC-3‟, Antisense-
5‟-CTTAGCACCACCCTTCAGATG-3‟), using the program: 94C for 15 min, 30 
cycles of 64C for 30 sec, 59C for 30 sec, and 72C for 30 sec, and 64C for 15 min.   
Agarose gel electrophoresis of the amplification products using a 2% agarose gel 
was done to check cDNA integrity.  To make the gel, 150 mL of 1X tris/borate/EDTA 
buffer (TBE) was added to 3 g agarose (Bio-Rad, Hercules, CA).  The flask was 
microwaved until the agarose was melted (approximately one minute on high power).  
Three microliters of 10 mg/mL ethidium bromide (Promega, Madison, WI) was added to 
the agarose solution after approximately one minute, and swirled to mix.  The gel was 
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poured into a BioRad Sub-Cell GT System Horizontal Gel Electrophoresis System with 
a 15x15 cm gel tray size (Bio-Rad, Hercules, CA) and cooled until solid.  The solidified 
gel was covered with 1X TBE.  A 5 µL aliquot of amplification product and 1 µL of 6X 
blue gel loading dye (New England BioLabs, Ipswich, MA) were used in each well.  The 
amplification products were separated following electrophoresis at 140 volts for 50 
minutes.  Bands were visualized using a Kodak EDAS 290 Electrophoresis 
Documentation and Analysis System (Kodak, Rochester, NY).   
 Seventeen genes that displayed changes in gene expression by microarray 
analysis were chosen for q-RTPCR, with gene choice based upon genes shown to be 
necessary for VLDL assembly found using the literature.  Included in this list were both 
induced and repressed genes that either showed significant change from baseline 
expression levels or did not show a significant change in expression level .  Genes whose 
expression level did not change significantly as judged by microarray analysis were 
amplified using two different time point samples in the q-RTPCR analysis.  Quantitative 
real time PCR was done to determine if microarray outcomes were trustworthy and 
repeatable.  A list of gene symbols, gene names, and primers employed for q-RTPCR are 
shown in Table 7. 
Primers were designed using the Roche Universal Probe Library (Roche Applied 
Science, Indianapolis, IN).  First, the gene‟s nucleotide sequence was found using the 
Ensembl online software (http://uswest.ensembl.org/index.html).   
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Table 7: Primer names and sequences used in q-RTPCR analysis. 
Gene Name GenBank Accession Primers 
HSP-70 NM_001006685 F: TCTGGGCACCACGTATTCTT 
  
R: GGCAATGATCTCCACTTTGC 
Glycerol-3-phosphate 
acyltransferase 
CR385377 F: AGTAAACTGTCGCCTTGCCTA 
  
R: CACCATTCCAGCAGCATTAC 
THRSP AY568628 F: AAGCTCTCACCCGGAGGTA 
  
R: CTCTGACCTTCACCGAGGTT 
LPL BU397801 F: AGAGTGAGAACATTCCTTTCACG 
  
R: GGAAGGAGAAGGTCTTGTTGG 
Apolipoprotein B 
(early sequence) 
M18421 F: TTCAGTCCAATCAGAGATTATGTCA 
  
R: CAGAAGGGTAGATAGTGGGATGTT 
Apolipoprotein B 
(later sequence) 
M18421 F: GCAGCTCAACGTTACAATTCC 
  
R: GCTGCCTACGGTCTTCTTTACA 
Vitellogenin II nm_001031276 F: CAGTAACTGTTGGCTTCCACTG 
  
R: TCTGTTTGTCAGTCAGGCTGTT 
D9D X60465 F: CCTGCGGATCTTCTTGACTATT 
  
R: GGGCCCACTCATAGATGTCA 
ApoVLDL-II M25774 F: ATGGTGCAATACAGGGCATT 
  
R: GTCAATGATGGACTTTGAGTGC 
Cyp 7A AY700578 F: TGGTTTCTTTTTGGGAGGAG 
  
R: TGGAAGGAACCCATTTTCAA 
Ppar-α AF163809 F: AATGGTCCAGGATCTGATGG 
  
R: GGCAAAATTAATGGATGAAGGA 
Fatty Acid Synthase J03860 F: TGAACTGTCCTCCAAGACTGG 
  
R: CTGGGCCTGTCTTCAACACT 
MTP BX934807 F: CCGAATGCAAGAAGTGTCCT 
  
R: AGGATGCATGTGTTCTTTGATG 
Riboflavin Binding Protein X74247 F: GAAGGGGACACCCACAAA 
  
R: TGTGAAGTTTGCATAGCAACAG 
LXR AJ851708 F: GAGCTACAACTCAATGATGCTGA 
  
R: GACTGGTCCTGCACATTCG 
Phosphatidylethanolamine 
N-methyltransferase 
AJ720523 F: CACAATTGCAGTGCTGTACGA 
  
R: GCTCCCTTCTGTTTCTGACG 
Hepatic Nuclear Factor 4-α AY700581 F: CAATGAATACGCCTGCTTGA 
  
R: GGATCGCTCAGTCCTTTGG 
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The sequence was input to the Universal Probe Library Assay Design Center 
(http://www.roche-applied-science.com/sis/rtpcr/upl/ezhome.html) beginning with a > 
symbol and with introns denoted using [].  The choice “Automatically Select an Intron 
Spanning Assay” was clicked.  The first primer option was chosen.  Primers were 
ordered from Integrated DNA Technologies (Integrated DNA Technologies, Coralville, 
Iowa), with a scale of 25 nanomole DNA and with the standard desalting purification 
option chosen.  The GAPDH primer pair sequences were obtained from the Dr. Michael 
J. Bailey lab, and were ordered in the same manner as listed above.  All seventeen 
primers were included in analysis, as no primer dimers were visualized on the melting 
curve during q-RTPCR.  Primer dimers appear on the q-RTPCR graph with two peaks 
instead of a single peak.   
The primers were first amplified using cDNA.  As described in the previous 
paragraph, the integrity of the products of the PCR amplification of the primers was 
determined by separation using electrophoresis on a 2% agarose gel and visualized by 
ethidium bromide staining using a Kodak EDAS 290 Electrophoresis Documentation 
and Analysis System (Kodak, Rochester, NY).  A 5 µL aliquot of amplification product 
and 1 µL of 6X blue gel loading dye (New England BioLabs, Ipswich, MA) were used in 
each well.  The PCR reactions including both forward and reverse primers were 
performed in a 10 ul reaction volume using SYBR Green PCR Master Mix (Applied 
Biosystems, Carlsbad, CA) and sample cDNA, on an ABI Prism 7900HT sequence 
detection system (Applied Biosystems, Foster City, CA). There was one “hot start” 
incubation stage (95°C for 10 min), one cycling stage (40 cycles of 95°C for 15 sec, 
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59°C for 30 sec, and 72°C for 30 sec), and one dissociation curve stage ( 95°C for 15 
sec, 60°C for 15 sec, and 95°C for 15 sec with a 2% ramp rate).  A dissociation curve 
was utilized to distinguish between specific and non-specific amplicons.  GAPDH was 
used as the internal control, or “housekeeping” gene.  GAPDH is a commonly used 
reference gene whose product is necessary to a cell‟s maintenance and survival; it is a 
gene that is expressed in cells at a constant level, therefore it is used as a standard for 
molecular assays [102].  All samples were measured in duplicate qRTPCR 
determinations.  Duplicates were averaged, and the single value used for further 
calculations and statistical analysis.  The comparative Ct method was used to calculate 
the relative gene expression level across the tissues using the ABI PRISM 7700 
Sequence Detection System, User Bulletin #2, part # 4303859 (The Perkin-Elmer 
Corporation, Waltham, MA).   
The relative expression level of each gene in one tissue (ΔCt) was calculated by 
Ct target gene-Ct GAPDH; relative expression of each gene in two different tissues 
(ΔΔCt) was calculated by ΔCt A -ΔCt B (The Perkin-Elmer Corporation, Waltham, 
MA).  The amount of target, normalized to an endogenous reference and relative to a 
calibrator, is given by: 2 
–ΔΔCT
 (The Perkin-Elmer Corporation, Waltham, MA).   
Molecular Measurements: Experiment 2 
RNA was extracted from all livers using the RNeasy Plus Mini Kit (Qiagen, 
Valencia, CA).  The concentration, level of organic contamination (260/230 ratio) and 
level of protein contamination (260/280 ratio) of each sample was determined using a 
NanoDrop spectrophotometer (Thermo Scientific, Waltham, MA).  Samples with ratios 
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outside of the desired range (1.7-2.0 for 260/280 and 2.0-2.3 for 260/230) were re-
purified by combining with 0.1 vol 3M sodium acetate, 3 vol 100% ethanol, and 3 vol 
glycogen and placed in a -80°C freezer for fifteen hours.  The samples were centrifuged, 
supernatant removed, and the resulting pellets washed with 75% ethanol.  Samples were 
then diluted to 800 µg RNA/µL in RNAse free water and replicate aliquots were stored 
frozen at -80C until used.  
A 1.0 ug aliquot of total RNA was used to synthesize first-strand cDNA using 
random hexamers and the Thermoscript™ RT-PCR system (Invitrogen, Carlsbad, CA) 
in a reaction volume of 20 μL. This reaction was done in a MJ Research PTC-200 Peltier 
Thermal Cycler (Bio-Rad Laboratories, Inc., Hercules, CA) with the following program: 
94C for 15 min, 30 cycles of 64C for 30 sec, 59C for 30 sec, and 72C for 30 sec, and 
64C for 15 min.  The resulting cDNA was used to amplify GAPDH primers (Sense-5‟-
GTGAGTCCACTGGTGTCTTCAC-3‟, Antisense-5‟-
CTTAGCACCACCCTTCAGATG-3‟) using the same time/temperature program.   
Agarose gel electrophoresis of the amplification products using a 2% agarose gel 
was conducted as described previously to verify cDNA integrity.  To make the gel, 150 
mL of 1X tris/borate/EDTA buffer (TBE) was added to 3 g agarose (Bio-Rad, Hercules, 
CA).  The flask was microwaved until the agarose was melted.  Three microliters of 10 
mg/mL ethidium bromide (Promega, Madison, WI) was added to the agarose solution 
after approximately 1 minute, and swirled to mix.  The gel was poured into a BioRad 
Sub-Cell GT System Horizontal Gel Electrophoresis System with a 15x15 cm gel tray 
size (Bio-Rad, Hercules, CA) and allowed to solidify at room temperature.  The gel was 
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covered with 1X TBE.  A 5 µL aliquot of amplification product was combined with  1 
µL of 6X blue gel loading dye (New England BioLabs, Ipswich, MA), resulting in a 1X 
concentration of blue gel loading dye in each well.  The gel was run at 140 volts for 50 
minutes.  Ethidium bromide stained bands arising from PCR were visualized using a 
Kodak EDAS 290 Electrophoresis Documentation and Analysis System (Kodak, 
Rochester, NY).   
 The genes listed in Table 7 used to evaluate the microarray outcomes from the 
estrogen induction study were used for quantification of hen mRNA using q-RTPCR.  
The PCR reactions were performed in a 10 ul reaction volume, combining  forward and 
reverse primers with sample cDNA, and using the SYBR Green PCR Master Mix 
(Applied Biosystems, Carlsbad, CA).  Analysis was done on an ABI Prism 7900HT 
sequence detection system (Applied Biosystems, Foster City, CA).  There was one “hot 
start” incubation stage (95°C for 10 min), one cycling stage (40 cycles of 95°C for 15 
sec, 59°C for 30 sec, and 72°C for 30 sec), and one dissociation curve stage ( 95°C for 
15 sec, 60°C for 15 sec, and 95°C for 15 sec with a 2% ramp rate).  GAPDH was used as 
the comparative control in order to control for experimental variations in the amount of 
RNA used for each q-RTPCR reaction as well as batch to batch variation in PCR 
reagents [102].  All of the samples were measured in triplicate. 
The three measurements for each tissue sample were averaged prior to further 
calculation or statistical analysis.  The comparative Ct method was used to calculate the 
relative gene expression level across the tissues. Relative expression level of each gene 
in one tissue (ΔCt) was calculated by: Ct target gene-Ct GAPDH; relative expression of 
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each gene in two different tissues (ΔΔCt) was calculated by: ΔCt A -ΔCt B.  During 
analysis, relative fold change was determined between the pre-production hens and the 
immediate pre-production hens, the pre-production hens and the laying hens, and the 
immediate pre-production hens and the laying hens. 
Bioinformatic Analysis: Experiment 1 
Imaging of the microarray is a first critical step to data analysis for this 
technique.  GenePix Pro 5.0 Personal 4100A array scanner and software (Molecular 
Devices, Sunnyvale, CA), was used to scan the microarrays at the level of 5 µm 
resolution; images from this analysis were saved in TIFF format.  Photomultiplier tube 
(PMT) gains were adjusted individually for each array to achieve a ratio of the overall 
intensities of the two channels (Cy3 and Cy5) of 0.95 to 1.05 [90].  Photomultiplier 
tubes are optical pieces of hardware that convert incident photons into electrons due to 
the photoelectric effect [103].  When an incident photon encroaches on the active surface 
of the photocathode, a photoelectron is generated [103].  The PMTs should be balanced 
so that the fluorescent intensities from both channels (635 nm and 532 nm) are similar 
[104].  The PMTs were adjusted so that the normalization factor, calculated by the 
GenePix Pro software, was close to one.  This optimizes dynamic range of the two 
channels and achieves the best visual effect of an image [104].  Second, each microarray 
feature (spot on the array) was manually identified and extracted by moving and 
changing the size of its feature identifier on the array grid using a GenePix Array List 
(GAL) file.  This was repeated for each of the 43,804 features on each of the twenty 
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arrays using the GenePix Pro 6.0 Software.  This is a total of 876,080 individual 
adjustments. 
The SNR is used to define the detection limit and the optimal PMT gain setting 
of the microarray scanner.  This value is calculated for each array element using the 
difference of the median intensity, minus the median background, divided by the 
standard deviation of the background [105].  The data from a gene feature was 
withdrawn from further analysis if it did not have at least one feature sampling spot on 
one array with an SNR greater than three.  This means that if a gene had SNRs of less 
than three at every sampling spot, the gene was deemed absent under the defined 
experimental conditions.  
Data were normalized using R [106].  Next, Lowess normalization, or locally 
weighted least squares regression, using a mixed linear model was performed with SAS 
(SAS, Cary, NC) to fit a smoothing curve onto the microarray dataset [107].  Lowess 
normalization is used to merge two-color data, such as in microarrays with two dyes 
used, and all samples in the dataset are corrected independently [107].  Genes with a 
significant SNR (SNR>3 at a minimum of one sampling point) and a p-value of less than 
0.05 were termed “significant” and included in further mathematical and statistical 
analysis. In this context the term “significant” implies that the gene is expressed at some 
level within the tissue being analyzed.   
JMP (SAS, Cary, NC) was then used as a comparative tool to determine uniquely 
shared genes between every possible time point combination, namely 1.5hr-3hr, 1.5hr-
6hr, 1.5hr-12hr, 1.5hr-24hr, 3hr-6hr, 3hr-12hr, 3hr-24hr, 6hr-12hr, 6hr-24hr, 12hr-24hr, 
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1.5hr-3hr-6hr, 1.5hr-3hr-6hr-12hr, 1.5hr-3hr-6hr-12hr-24hr, 3hr-6hr-12hr, 3hr-6hr-12hr-
24hr, and 6hr-12hr-24hr.  To use JMP, the following steps were followed: 
 The data from each time point was placed into a single excel file, with data from 
each time point located on individual worksheets within the Excel workbook.   
 JMP was opened.   
 Under the data file, the workbook name containing the individual worksheets 
with the data was chosen.   
 Click the first worksheet to be used in the comparison to activate. 
 Choose “Tables”, and then “Join”. 
 Next, choose the second worksheet to be used in the comparison. 
 The option “Gene Index” under each worksheet was highlighted as the point of 
comparison between the worksheets.  
 “Match” was clicked. 
 The option “Include non-matches” was clicked to include genes which are not 
shared by the two worksheets in the output file.   
 Choose “OK”. 
 A new JMP output file is created that can be saved with a unique file name.   
For genes that were included in JMP outcome files, and were on the array listed 
as “no hits”, “unknown”, or without a description, the GenBank ID was searched within 
the NCBI chicken specific map viewer 
(www.ncbi.nlm.nih.gov/mapview/map_search.cgi?taxid=9031).  To do this, the 
GenBank ID was entered in the “Search for” box and “Find” was clicked.  The search 
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results page produces a nucleotide sequence for the GenBank ID of interest.  This 
sequence was entered into the NCBI BLAST [108] program to determine homology to 
genes in other organisms, and to provide further information about the gene in the 
pursuit of gene identification.   
The DAVID web-based software was next used for large scale functional 
annotation of identified genes [92, 93].  The entire list of probes on the array, received 
from the microarray developers, was pasted into the DAVID upload box as a 
background for analysis.  The genes of interest (example: all 1,528 genes, with 
significantly different levels of expression at 1.5 hours when compared to 0.0 hrs) were 
pasted into the upload box as a gene list.  The “Identifier” selected in Step 2 is 
GENBANK_ACCESSION.  “Start analysis” was clicked and then “Functional 
Annotation Tool” was clicked.  Following analysis, the Uploaded List can be removed 
from the “List Tab” and the next set of genes can be input.  The background genes 
remain in the program for these additional analyses.   
Specific Gene Focus: Experiment 1 
 The first gene focused on was TAG hydrolase, an intracellular lipase that is 
believed to catalyze hepatic TAG store mobilization for VLDL assembly.  The term 
“triacylglycerol hydrolase” was searched in the Genecards (www.genecards.org) 
database[97].  Carboxylesterase 1 (CES1) was chosen, as it is an also known as term for 
triacylglycerol hydrolase.  In the section labeled “Gene Function for CES1 gene” the 
Enzyme Number (IUBMB) was noted to be 3.1.1.1.  Next in Uniprot (www.uniprot.org) 
this IUBMB number was searched for further information.   
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 The death domain genes and cell-death-inducing DFF45-like effector (CIDE) 
genes were investigated next.  CIDE genes are a family of cell death activators with 
homology to the 45 kDa subunit of the DNA fragmentation factor that play an important 
role in lipid metabolism[109].  CIDE-B has specifically been shown to mediate VLDL 
lipidation and maturation by interacting with apolipoprotein B [110].    
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CHAPTER III 
ESTROGEN INDUCTION OF MALE CHICKS  
 
Introduction  
The chicken egg is a product of an intense, hormone driven process that creates 
an environment fit for the incubation of a chick embryo.  Important to the chick‟s 
survival is an adequate supply of energy which is shuttled to the egg in the form of 
VLDLy, a TAG rich lipoprotein.  TAG is the most concentrated form of stored energy, 
and the 6.0 g of TAG in an egg yolk is enough for the chick‟s survival prior to hatch [1].  
It has been observed that estrogen treatment of male birds mimics the effects of female 
sexual maturation on circulating lipoprotein profiles [60]; in that same study by Luskey, 
ApoB-LP assembly in male birds was seen to increase fourfold 16 hours after estrogen 
treatment [60].  We hypothesized that inducing seven to ten day old male chicks with 
estrogen would produce effects on hepatic ApoB-LP assembly similar to that of a hen 
reaching sexual maturity.  Expanding on earlier estrogen induction studies, the Agilent 
44K Chicken Array was used to measure levels of individual mRNA transcripts in the 
livers of chicks.   
As all aspects of the VLDL assembly process are not known, microarray 
technology was used to compare the temporal expression patterns of genes in a tissue 
(liver) known to be involved in VLDL assembly under conditions where this process is 
known to be undergoing rapid and massive increases in capacity.  One of our aims was 
to evaluate a strategy to cluster genes with similar kinetic schemes in order to determine 
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whether additional biological inference about their contribution to higher order 
biological processes.  Specifically, we wondered whether previously unrelated genes 
could be specifically associated with VLDL assembly by having a kinetic pattern similar 
to that of ApoB100.  In a second approach a list of candidate genes shown to be essential 
to the VLDL assembly process was identified using peer-reviewed literature.  The 
stipulations for inclusion in the candidate gene list are listed in Chapter I. 
Materials and Methods 
Based on a scheme described in Chapter II, and also described in Table 5 and 
Figure 2, four chicks were exposed to estrogen for each of the following lengths of time: 
0, 1.5, 3, 6, 12, 24 hours post-estrogen exposure.  Birds were killed at a constant clock 
hour by exsanguination via cardiac puncture.  Following full sedation, livers were 
quickly removed and frozen on dry ice.   
RNA was extracted from all livers with the Ribopure kit using approximately 10-
15 mg of tissue and according to standard kit protocol (Ambion, Foster City, CA).  
Following concentration determination, select samples were concentrated using a  
sodium acetate precipitation, thoroughly described in Chapter II.  Denaturing agarose gel 
electrophoresis was done to measure RNA integrity.   
Highly concentrated RNA samples with clear bands on a denaturing gel and 
acceptable 260/280 and 260/230 ratios were labeled and hybridized to an Agilent 
microarray using a dual dye system (Santa Clara, CA).  RNA isolated from samples 
taken at time points 24, 12, 6, 3, and 1.5 was hybridized with one zero time point control 
sample, creating four replicates of the time course. 
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Features were extracted and optimized as listed in Chapter II.  The SNR was 
calculated for each array element using the difference of the median intensity, minus the 
median background, divided by the standard deviation of the background [105].   
Data were normalized using R [106].  Lowess normalization using a mixed linear 
model was performed with SAS (SAS, Cary, NC) [107].  Genes with a p-value of less 
than 0.05 were termed significant and included in analysis.  The program JMP (SAS, 
Cary, NC) was then used as a comparative tool to determine uniquely shared genes 
between every possible time point combination described in Chapter II. 
Unknown sequences of interest were found using the NCBI map viewer 
(www.ncbi.nlm.nih.gov/mapview/map_search.cgi?taxid=9031).  Sequence was entered 
into the NCBI BLAST [108] program to determine homology to genes in other 
organisms, and to identify the gene.  The web-based DAVID software was next used for 
large scale functional annotation of identified genes [92, 93].   
 Total RNA was used to synthesize first-strand cDNA as described in Chapter II.  
cDNA integrity was tested by amplifying GAPDH primers and running the amplification 
product on an agarose gel.  Next, q-RTPCR was used for quantification of seventeen 
genes of interest to qualify microarray results.  All samples were measured in duplicate, 
and values averaged prior to further computational analysis.  Following measurement, 
the comparative Ct method was used to calculate the relative gene expression level.   
A list of candidate genes was created apart from any microarray data (Table 2).  
The stipulations for inclusion in the candidate gene list are listed in Chapter I.  Briefly, 
when the gene in question was absent or altered VLDL assembly failed or was otherwise 
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compromised, the gene was shown or speculated to be involved in assembly of an apoB-
LP or to be a structural part of an apoB-LP, the gene was shown or speculated to be 
estrogen responsive, or the gene was responsible for a protein involved in making lipids 
or transporting lipids.  These genes were compared to the results seen in the chick 
estrogen induction model.  It was noted whether the genes on the candidate gene list 
showed significant changes in transcript levels as estimated by binding to microarray 
probes in the chick estrogen induction model.  Next, the genes in the candidate gene list 
were placed into groups with candidate genes that have similar functions or are 
structurally. 
Results 
Seventeen genes were tested using q-RTPCR to qualify the microarray results.  
The coefficient of variation (CV) between the replicate q-RTPCR reactions ranged from 
1%-5%, with a mean CV of 4.1% ± 1.0%.  The outcomes of q-RTPCR are listed in 
Table 8.  For testing purposes, several genes that were not differentially expressed in 
relation to time 0 in the microarray experiment were chosen for q-RTPCR inclusion.  For 
these genes, samples from two different time points were tested using q-RTPCR.  These 
gene names are denoted with a „*‟ in Table 8.  Statistical significance values are 
presented in Table 9.  Standard deviation and standard error of the mean compare the 
raw Ct values from q-RTPCR at one time point.  The student‟s t-test compares the Ct 
values of a gene at the noted time point to the Ct values of the same gene at time 0. 
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Table 8. Fold differences in expression between an internal reference gene 
(GAPDH) and target genes using q-RTPCR.  Those gene names with a * are genes 
tested against samples at two time points for additional confidence. 
Gene Name 1.5hrs 3hrs 6hrs 12hrs 24hrs 
Heat Shock Protein 
70kDa* 
-2.08 - - - -1.45 
Glycerol-3-phosphate 
acyltransferase-3* 
- 1.20 - - -2.56 
Thyroid hormone 
responsive spot 14 
- - -3.33 - - 
Lipoprotein Lipase - - - - -7.69 
Apolipoprotein B (taken 
from early part of ApoB 
sequence) 
-1.39 - - - - 
Apolipoprotein B (taken 
from late part of ApoB 
sequence) 
- - - 10.36 - 
Vitellogenin 1I - 849.70 - - - 
Delta 9 Desaturase* 1.62 - - 2.17 - 
Very low density 
lipoprotein II 
- - 6618.62 - - 
Cytochrome P450, family 
7, subfamily A * 
- 1.38 - 2.95 - 
Peroxisome Proliferator –
Activated Receptor   
- - - -1.43 - 
Fatty Acid Synthase - - -1.67 - - 
Microsomal Triglyceride 
Transfer Protein 
- - - - -4.55 
Riboflavin Binding 
Protein 
- - 33.71 - - 
Liver X Receptor* 1.08 1.53 - - - 
Phosphatidylethanolamine 
N-methyl transferase 
- - - 1.87 - 
Hepatocyte Nuclear 
Factor 4 alpha* 
- - - 1.16 0.76 
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Table 9. Statistical outcomes of chick q-RTPCR results. 
Gene Name Time Point 
Standard 
Deviation 
Standard 
Error of the 
Mean 
Student‟s 
T-Test p 
value 
Heat Shock Protein 
70kDa 
1.5hrs 1.31 0.46 0.06 
Heat Shock Protein 
70kDa 
24hrs 1.38 0.49 0.39 
Glycerol-3-phosphate 
acyltransferase-3 
3hrs 0.94 0.33 0.65 
Glycerol-3-phosphate 
acyltransferase-3 
24hrs 2.00 0.76 0.06 
Thyroid hormone 
responsive spot 14 
6hrs 0.88 0.31 0.06 
Lipoprotein Lipase 24hrs 2.28 0.86 0.01 
Apolipoprotein B 
(early) 
1.5hrs 1.06 0.37 0.48 
Apolipoprotein B (late) 12hrs 0.30 0.14 2.12E-5 
Vitellogenin 1I 3hrs 1.45 0.51 9.39E-8 
Delta 9 Desaturase 1.5hrs 1.41 0.50 0.76 
Delta 9 Desaturase 12hrs 0.92 0.35 0.053 
Very low density 
lipoprotein II 
6hrs 0.59 0.24 7.94E-10 
Cytochrome P450, 
family 7, subfamily A 
3hrs 1.73 0.65 0.81 
Cytochrome P450, 
family 7, subfamily A 
12hrs 1.62 0.57 0.0079 
Peroxisome Proliferator 
–Activated Receptor   
12hrs 0.27 0.10 0.48 
Fatty Acid Synthase 6hrs 0.56 0.21 0.63 
Microsomal 
Triglyceride Transfer 
Protein 
24hrs 3.06 1.08 0.095 
Riboflavin Binding 
Protein 
6hrs 0.95 0.34 2.40E-10 
Liver X Receptor 1.5hrs 0.89 0.31 0.91 
Liver X Receptor 3hrs 0.94 0.33 0.68 
Phosphatidylethanolami
ne N-methyl transferase 
12hrs 0.47 0.16 0.003 
Hepatocyte Nuclear 
Factor 4 alpha 
12hrs 1.24 0.44 0.09 
Hepatocyte Nuclear 
Factor 4 alpha 
24hrs 1.71 0.61 0.68 
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After JMP analysis comparing all possible combinations of time points, it was 
determined that an interesting JMP comparison was the comparison of all possible time 
points (1.5-3-6-12-24).  This comparison determined that 119 genes were differentially 
expressed as compared to time 0 at every time point.  
When the NCBI map viewer was utilized to identify the 119 genes expressed at 
every time point, several interesting points were determined.  Six of the 119 probes (5%) 
showed no identity to annotated amino acid sequences.  Thirty-four of the 119 probes 
(29%) showed 98%, 99%, or 100% of identity to annotated amino acid sequences.  
Fifteen of the 119 probes (13%) showed identity to a predicted, hypothetical, or 
unknown annotated amino acid sequence.  The remaining 53% of genes were identified 
on the Agilent 44K Chicken Array. 
ApoB had five probes on the microarray, each assessing a different region of its 
4536 bases.  The expression patterns of each probe differed (Figure 3).  BX258989 (nt 
2,517 to nt 2,576) had the highest individual fold change of the probes, peaking at a fold 
change of 7.6 at 6 hrs (Figure 3).  BX258989 also had the highest fold change at every 
other time point except for 24 hrs.  At 24 hrs, BU125204 (nt 33,310 to nt 33,369) had the 
highest fold change.  BX935480 (nt 10,608 to nt 10,667) had the lowest fold change at 
1.5, 3, and 6 hrs. CR407271 (nt 27,799 to nt 27,858) had the lowest fold change at 12 
and 24 hrs. CR407271 is located late in the ApoB sequence.   
Candidate genes were chosen, based upon the stipulations listed in Chapter I.  
Briefly, genes that had been shown to significantly impact VLDL assembly or secretion 
in a natural or induced gene absence were included.   
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Figure 3. Expression patterns of five apoB probes analyzed by microarray. 
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When these report findings were compared to the chick estrogen induction data, 
it was seen that expression levels of 31 of the 61 candidate genes found in literature 
(51%) were not significantly different at any time point post estrogen exposure.  Fold 
changes for candidate genes are seen in Table 10.  Of the candidate genes, seven unique 
genes had differential expression in relation to time 0 at all five time points.  Several of 
these seven genes had two probes on the microarray.  The seven genes included 
AGPAT-2, HSP70, ApoB, RBP, VLDLII, VTGI, LPL.  Of the thirty genes with 
differential expression, ten had negative fold changes. 
The candidate genes were next organized into groups involved in similar 
processes.  The first group of genes was the nuclear transcription factors associated with 
either assembly specifically or with genes responsible for particle component synthesis.  
These genes included forkhead box A2 (FOX A2), HNFα, vitamin D3 receptor, and 
calreticulin.  The first, FOX A2, was differentially expressed in relation to time 0 and the 
last three were not.  FOX A2 regulates gene expression in differentiated tissues; it is a 
transcriptional activator for liver-specific genes like albumin and transthyretin. 
Another group included genes known to be involved in VLDL assembly, namely 
ApoB, MTP, choline kinase (CHK, E.C. 2.7.1.32), diacylglycerol O-acyltransferase 2 
(DGAT2, E.C. 2.3.1.20), 1-acylglycerol-3-phosphate O-acyltransferase 3 (AGPAT-3, 
E.C. 2.3.1.51), phosphatidylethanolamine N-methyltransferase (PEMT, E.C. 2.1.1.17), 
which were all regulated at one or more time points.  These genes are directly involved 
in particle component synthesis or putting together the interdependent parts of a VLDL.   
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Table 10. Fold changes of candidate genes whose level of transcription 
differed significantly from 0 hour post estrogen exposure.  Gene names listed 
twice represent a gene with two probes on the microarray.  
Gene Name Accession 1.5hr 3hr 6hr 12hr 24hr 
Fatty Acid 
Synthase 
BU301374 - - - - -1.59 
Diacylglycerol O-
Acyltransferase 2 
BX275561 - -1.43 -1.54 - - 
Glycerol-3-
phosphate 
acyltransferase-2 
BU295914 1.77 2.89 3.57 4.56 1.87 
Glycerol-3-
phosphate 
acyltransferase-3 
CR385377 - - - - -1.67 
Thyroid Hormone 
Responsive Spot 
14 
AY568628 - -1.75 -2.44 - - 
Ferritin repressor 
protein 
D16150 1.46 1.78 1.81 1.84 - 
Cytochrome 
P450, Family 51 
BU467769 - - - - 2.05 
Cytochrome 
P450, Family 51 
BU221671 - - - - 1.78 
Squalene synthase AJ719973 - - -3.13 - - 
HMG CoA 
Synthase-1 
M60657 2.51 2.38 - - - 
Microsomal 
Triglyceride 
Transfer Protein 
BX934807 -1.67 -1.89 -2.17 -2.04 - 
Heat Shock 
Protein 70 
BU308587 -1.75 -2.17 -2.04 -1.72 -1.75 
Heat Shock 
Protein 90 kDa 
beta 
M14772 -2.70 - - - - 
Heat Shock 
70kDa Protein 5 
M27260 -3.13 - - - -2.44 
Heat Shock 
Protein Cognate 
Beta 
X70101 -1.64 -1.79 -1.59 - - 
Apolipoprotein B M18421 1.61 2.39 3.71 4.61 2.74 
Apolipoprotein B BU125204 1.72 2.50 3.30 4.51 2.82 
Riboflavin 
Binding Protein 
X74247 6.27 11.24 20.62 45.22 56.24 
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Table 10 Continued 
 
Gene Name Accession 1.5hr 3hr 6hr 12hr 24hr 
Riboflavin 
Binding Protein 
J03922 4.06 10.47 17.80 59.44 45.53 
Dolichyl 
Pyrophosphate 
Phosphatase-1 
BX932586 - - - - -1.35 
Phosphatidyletha-
nolamine N-
methyltransferase 
AJ720523 - - - 1.93 - 
Choline Kinase CF257275 4.51 5.19 5.10 5.10 - 
Very low density 
lipoprotein II 
M25774 142.32 151.74 177.01 94.06 90.50 
Very low density 
lipoprotein II 
V00449 113.19 102.14 127.13 80.67 75.97 
Vitellogenin I D89547 - 8.13 57.33 
111.7
6 
56.87 
Vitellogenin I BU125536 41.56 163.19 226.93 51.32 65.57 
Liver Fatty Acid 
Binding Protein 
AF380999 - - 2.37 1.62 1.85 
Lipoprotein 
Lipase 
BU397801 -4.00 -7.69 -6.67 -6.25 -2.22 
VLDL receptor X80207 - 1.74 - - - 
Cell death-
inducing DFFA-
like effector a 
BU456248 - - - - 2.39 
Diazepam 
Binding Inhibitor 
BU476960 - - 1.42 1.78 1.74 
Malic enzyme 3 
BQ038051.
2 
- - 2.64 - - 
Carboxy-terminal 
domain, RNA 
polymerase II, 
polypeptide A 
phosphatase, 
subunit 1 
CR387746 - -1.43 -1.49 -1.37 -1.41 
Forkhead Box A2 AF150749 - -1.45 - - - 
Insulin Induced 
Gene 1 
AJ719295 2.33 2.33 - - - 
Fas associated 
factor family 
member 2 
CR387756 - 1.44 - - - 
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Several candidate genes involved in VLDL assembly which were expected to be 
differentially expressed when compared to time 0, but were not, included ACC, lipin 1 
(LPIN1), and fatty acid elongase (ELOVL, E.C. 2.3.1).  A reproduction specific gene 
group was comprised of RBP, VTGI, and ApoVLDL-II.  Transcription of these genes 
was shown by other studies to be estrogen dependent [26-30] and their transcription is 
increased in the presence of estrogen (Figure 4).  ApoVLDL-II‟s transcript is stabilized 
by estrogen [26].  As estrogen declines, ApoVLDL-II is no longer stable and the protein 
is not present.  These genes were all seen to be differentially expressed compared to time 
0 in the estrogen induced chick model (Figure 4). 
A candidate gene group involved in glycerol lipid synthesis included the 
regulated FAS, acyl-CoA:diacylglycerol acyltransferase, 1-AGPAT-2, 1-AGPAT-3, 
thyroid hormone responsive spot 14 (THRSP), and aconitase (E.C. 4.2.1.3).  The genes 
with unchanging expression levels in this group included ATP citrate lyase (ACLY, E.C. 
2.3.3.8), ACC, D9D, ELOVL, 6-phosphogluconate dehydrogenase (PGD, E.C. 1.1.1.44), 
and 5' adenosine monophosphate-activated protein kinase (AMP-K, E.C. 2.7.11). 
Conclusions 
 The results observed from the chick estrogen induction trial aligned with the 
individual steps required for VLDL assembly.  31 out of 61 candidate genes (51%) were 
seen to significantly change at one or more time points.  Vitellogenin I, lipoprotein 
lipase (LPL), and ApoVLDL-II were three genes included on the candidate gene list 
whose expression level was significantly different from 0 time at one or more time 
points.   
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Figure 4. Changes in the expression of estrogen responsive genes following a single 
maximally stimulating estrogen dose.  Note: Vitellogenin I and Very Low Density 
Lipoprotein II data are an average of two probe fold changes. 
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Vitellogenin I, an estrogen responsive gene, peaked at a fold change of 166 at 
3hrs.  Lipoprotein lipase was a gene that was suppressed 8 fold at 3hrs.  ApoVLDL-II, 
another estrogen responsive gene, peaked at a fold change of 177 at 6hrs. 
Not all of the genes expected to be necessary for VLDL assembly were seen to 
be differentially expressed as compared to 0 time across the time course.  This may be 
due to variations in the chicken‟s physiology as compared to a human or mouse model, 
or other variations in the experiment, including factors like feeding state, time of day, or 
physiological stage of the animal.  Alternatively, the expression levels of these genes 
may not have been limiting to increases in VLDL assembly and so alteration in their 
expression was not needed. 
 When observing the 24-hour time course, it was clear that gene programs were 
predominantly working to prepare the cell to produce VLDL for three to six hours post 
estrogen exposure.  These preparatory processes included increases in mRNA 
responsible for ribosome synthesis, specific structural proteins like ApoB and 
ApoVLDL-II, lipids, and expression of proteins that serve to reduce cell stress.  Later 
regulated processes (6-24 hours) were predominately related to lipid filling and lipid 
transport, most likely correlated to the assembly of a VLDL.  This information formed 
the rationale of what we expected the gene expression patterns of the laying hen survey 
to be; the pre-lay transitioning to immediate pre-lay hens were expected to have more 
genes in common with the 0-6 hour chick data, and the laying hen gene expression was 
expected to be more like the 6-24 hour chick data. 
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CHAPTER IV 
NATURAL ESTROGEN EFFECTS ON PULLETS 
 
Introduction 
We hypothesized that patterns of change in mRNA levels of estrogen induced 
male chicks would be similar to those of hens naturally approaching and achieving 
sexual maturity.  To test this idea, changes in gene expression of female chickens 
undergoing the pullet to layer transition were studied.  Towards this end, four pullets, 
15wk 4d old, (~12wk prior to lay), four pullets, 16wk 3d old, (~11wk prior to lay), and 
four hens, 24wk 1d old, (actively laying), were used in this experiment.  The data from 
these twelve birds was compared to the data from the twenty-four estrogen induced 
chicks to identify similarities and differences in expression of seventeen selected genes. 
We expected the same genes whose expression increased massively in the 
estrogen induced chicks at three and six hours to be similarly elevated in laying hens in 
comparison to 15 wk old pullets.  Three hours and six hours were judged “maximal” for 
gene expression.  The pre-production and immediate pre-production hens were expected 
to have similar gene profiles to the chicks exposed to estrogen for 1.5 to 6 hours, 
respectively.  This hypothesis was based on the fact that estrogen is responsible for the 
physiologic and gene expression changes that occur in a hen allowing it to produce an 
egg, and the idea that estrogen levels in a hen are in flux as it reaches sexual maturity.   
 
 
68 
 
Materials and Methods 
Twelve female chickens at different stages of reproductive maturity were studied. 
Four pre-production pullets, four immediate pre-production pullets, and four egg-laying 
hens were used. Hens were killed and blood and livers collected according to section 2. 
Each hen‟s body weight, liver weight, pelvic width at the midpoint of the ischium, ovary 
weight, oviduct weight, ovarian status, and follicle presence and weight were noted.  
After blood processing, the diameters of lipoproteins recovered from the floating 
lipid layer were measured using a Nanotrac UPA 250 (Microtrac software version 10.5, 
Clearwater, FL).  A complete description is found in section two.  A portion of the 
processed plasma was sent to the Texas Veterinary Medical Diagnostic Laboratory on 
the campus of Texas A&M University for 17β-Estradiol quantification to assess estrogen 
levels in the pre-production, immediate pre-production, and laying hens.  Briefly, 1.0 mL 
of dichloromethane was added to 0.5 mL plasma sample to extract estrogens.  Solvent 
was evaporated from plasma extracts, and rehydrated with phosphate buffered saline.  A 
200 µl aliquot of the solubilized extract was used in each duplicate for 
radioimmunoassay using the Siemens Estradiol Double Antibody Kit #KE2D1 
(Siemens, Munich, Germany).  The sample was incubated with antibody supplied with 
the kit for 2hrs, and then incubated for 1hr with the tracer supplied with the kit.  Finally, 
the antibody bound fraction was precipitated and counted using a Genesys 5000 gamma 
counter Model LTI505 (Laboratory Technologies, Inc., Maple Park, IL).  
RNA was extracted from all livers using the RNeasy Plus Mini Kit (Qiagen, 
Valencia, CA).  cDNA was synthesized using random hexamers and the Thermoscript™ 
69 
 
RT-PCR system (Invitrogen, Carlsbad, CA).  Second, the cDNA was used to quantify 
the transcript levels of the same seventeen genes used in section three using q-RTPCR.  
See Chapter II for a complete protocol. 
Results 
The pre-production (15wk 4d), immediate pre-production (16wk 3d), and laying 
hens (24wk 1d) had an average body weight of 1033.3 g ± 30.4 g, 1183.8 g ± 50.7 g, and 
1448.5g ± 64.4 g, respectively.  Average liver weight as percent of body weight was 
2.30% ± 0.27% for pre-production, 2.49% ± 0.078% for immediate pre-production, and 
2.48% ± 0.15% for laying hens.  Average pelvic width was 2.71 cm ± 0.085 cm, 5.75 cm 
± 0.32 cm, and 6.38 cm ± 0.24 cm for pre-production, immediate pre-production, and 
laying hens, respectively.  Average ovary weight drastically increased: 0.42 g ±0.073 g 
for pre-production, 0.84 g ± 0.061 g for immediate pre-production, and 57.22 g ± 7.68 g 
for laying hens.  Average oviduct weight increased from 0.56 g ± 0.094 g in pre-
production hens to 15.32 g ± 0.82 g in immediate pre-production hens to 51.69 g ± 5.07 
g in laying hens.  There were no follicles present in the pre-production hens.  There were 
follicles present in one of the immediate pre-production hens; this hen had two follicles, 
F1 of 0.40 g and an F2 of 0.34 g.  The laying hens had multiple follicles.  The average 
weights of follicles F1 through F6 of the laying hens were 12.99 g ± 0.95 g, 12.4 g ± 
1.28 g, 9.67 g ± 1.72 g, 6.68 g ± 1.55 g, 4.52 g ± 1.50 g, and 4.46 g ± 0.30 g, 
respectively.  The average VLDL diameter was 72.40 nm ± 10.18 nm in the pre-
production hens, 21.95 nm ± 0.71 nm in the immediate pre-production hens, and 26.97 
nm ± 0.96 nm in the laying hens.  This physiologic data is summarized in Table 11. 
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Table 11. Hen physiological data.  Each data point is an average of four 
birds.  Note:  Follicles are not present in immature birds, thus follicle weights 
are not available and statistics are not possible. 
Feature Measured 
Pre-Production 
Hens 
Immediate Pre 
Production 
Hens Laying Hens 
Sacrifice Time 14:52 14:43 15:33 
Body Wt 1033.25 g 1183.75 g 1448.50 g 
Liver Wt 23.72 g 29.44 g 35.89 g 
Liver Wt as a % of Body Wt 2.30% 2.49% 2.48% 
Pelvic Width 2.71 cm 5.75 cm 6.38 cm 
Ovary Wt 0.42 g 0.84 g 57.22 g 
Oviduct Wt 0.56 g 15.32 g 51.69 g 
F1 Wt n/a 0.09 g 12.99 g 
F2 Wt n/a 0.10 g 12.40 g 
F3 Wt n/a n/a 9.67 g 
F4 Wt n/a n/a 6.68 g 
F5 Wt n/a n/a 4.52 g 
F6 Wt n/a n/a 4.46 g 
VLDL Diameter  72.40 nm  21.95 nm 26.97 nm 
Plasma Estrogen Levels  109.00 pg/uL 177.95 pg/uL 37.15 pg/uL 
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Average pelvic width was positively correlated with the VLDL diameter (nm) 
when average (Figure 5).  The trend line of average plasma estrogen concentration was 
also negatively correlated with pelvic width, oviduct weight, and liver weight.  
17β-Estradiol analysis showed that the immediate pre-production hens had the 
highest average of plasma estrogen, with 109.0 ± 74 pg/mL. The pre-production hens 
had an average plasma estrogen of 178.0 ± 84 pg/mL. The laying hens had the lowest 
concentration of plasma estrogen, with 40.9 ± 5.5 pg/mL. This general pattern aligns 
with a study by McKeegan which showed that a laying hen‟s plasma estrogen level 
peaks at approximately 200 pg/mL around 15-17 weeks, and drops to approximately half 
of that by 24 weeks [111].  
Seventeen genes were analyzed using q-RTPCR. The pre-production hens were 
compared with the immediate pre-production and the laying hens to determine fold 
changes of gene expression.  In addition, the immediate pre-production hens were 
compared with the laying hens to determine fold changes in gene expression. This data is 
summarized in Table 12.  The average standard deviation for each set of replicates of a 
gene was 1.41.  Six genes showed negative gene expression patterns in relation to 
another maturity group of birds.  Cyp 7A and HNFα were the genes whose expression 
was observed to be both up and down in comparison to one of the other bird age groups.  
VTGII had the highest expression level (1653.2) as compared to time 0 of all 
comparisons, and riboflavin binding protein had the second highest fold change (851.8).   
 
 
72 
 
 
Figure 5. Comparison of VLDL diameter trend line to average pelvic width trend 
line. 
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Table 12. Hen q-RTPCR results. 
Gene Name Pre-production and 
immediate pre-
production 
Immediate pre-
production and lay 
Pre-production and 
lay 
 
HSP-70 1.03 3.79 3.92 
1-AGPAT 3 1.39 1.67 2.31 
THRSP -1.06 -2.27 -2.44 
LPL -6.25 -2.04 -12.50 
ApoB (early) 7.06 1.55 10.93 
ApoB (late) 4.58 1.73 7.90 
VTGII 638.36 2.59 1653.20 
D9D -2.44 -1.30 -3.23 
ApoVLDL-II 63.98 3.05 194.87 
Cyp-7A 1.39 -1.89 -1.35 
Ppar-alpha 1.56 1.11 1.73 
Microsomal 
Triacylglyceride 
transfer protein 
(MTP) 
-2.04 -1.43 -2.94 
Riboflavin binding 
protein 
161.50 5.27 851.80 
LXR 1.32 2.00 2.65 
PEMT 1.08 2.20 2.37 
Hepatic Nuclear 
Factor-alpha 
-1.64 10.34 6.34 
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Conclusions 
Physical examination of birds at necropsy showed that pre-production hens‟ 
ovarian status was extremely undeveloped, the immediate pre-production hens‟ ovarian 
status was clearly developing, and the laying hens‟ ovarian status was fully developed.  
This anatomical data combined with physiologic data confirmed that the terms pre-
production, immediate pre-production, and laying hens were correct for the stage of 
sexual development assigned to each group. Based upon the increase in oviduct and 
ovary weight, it was apparent that the hens physically progressed into sexually maturity 
very quickly. 
One interesting find was the concentration of estrogen in the different aged hens. 
We initially expected the laying hens to have the highest level of plasma estrogen of the 
three sets of birds, as they were actively undergoing lay and producing approximately 
one egg per day. What was seen, though, was that the laying hens had the lowest 
concentration of estrogen in the plasma among the three groups. The birds with the 
highest level of estrogen in their plasma were the immediate pre-production pullets, 
which were ~eleven weeks from lay. It can be ruled out that estrogen levels differed due 
to the time of death, because the immediate pre-production pullets were killed from 
14:40 hrs to 14:48 hrs, which was very similar to the time of death of the pre-production 
hens (14:51 hrs to 14:54 hrs). The laying hens had the latest time of death, from 14:58 
hrs to 15:59 hrs. It could be hypothesized that these hens were undergoing drastic 
physiological changes preparing their bodies for egg production.   
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One clue to support this idea is the rapid 27-fold increase in oviduct weight in the 
one week period between the harvest of the pre-production and immediate pre-
production hens.  The average oviduct weight increased from 0.56 g to 15.32 g, as the 
average plasma estrogen concentration increased from 109.00 pg/mL to 177.95 pg/mL. 
The general pattern of change in estrogen concentration observed in our study aligns 
with a study by McKeegan which showed that a laying hen‟s plasma estrogen level 
peaks at approximately 200 pg/mL around 15-17 weeks, and drops to approximately half 
of that by 24 weeks [111]. 
The q-RTPCR analysis showed that VTGII, ApoVLDL-II, and RBP had massive 
upregulation, as expected.  Another interesting thing noticed from q-RTPCR analysis 
was the difference in expression between the two ApoB primers.  The primer which is 
early in the ApoB sequence had a fold change of 10.93 when the pre-production and 
laying hens were compared.  Using this same comparison, the primer localized later in 
the ApoB sequence had a fold change of 7.90.  This differential degree of expression 
was also observed in the microarray results from the estrogen induced chicks (Figure 3).  
It is thought that the placement of the sequence to be amplified plays a role in efficiency 
of the amplification and affects the actual amplification results.  This may be due to the 
aspects of the particular amplification procedure used or simply the length of the mRNA 
sequence. 
The q-RTPCR outcomes from both estrogenized male chicks and female 
chickens at the pullet-layer transition were used in general comparisons to one as a way 
to evaluate the similarity in patterns of gene expression and perhaps provide a 
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physiological frame of reference for the estrogen induction protocol.  Comparisons 
between pre-lay and immediate pre-lay pullet patterns of gene expression were similar in 
magnitude to the changes observed in comparisons of estrogen naïve male chicks to 
those exposed to estrogen for 1.5hr to 6hrs.  Specifically, VTGII had its greatest fold 
change in male chicks during this time frame, and similarly the greatest fold of 166 at 
3hrs in the estrogen induced chick microarray.  In the hen q-RTPCR data, the largest 
fold change was 638, seen when the same pre-lay to immediate pre-lay comparison was 
made.  In just seven days, the hens exhibited massive changes that caused VTGII 
expression to increase.  In the estrogen induced chicks, LPL was suppressed 8 fold at 
3hrs.  In the hens, LPL was maximally suppressed 6-fold when pre-lay and immediate 
pre-lay birds were compared.  ApoVLDL-II, peaked at 6 hrs at a fold change of 177.  
When the pre-lay and immediate pre-lay birds were compared, ApoVLDL-II had its 
maximal fold change of 64.  The estrogen induced chick model clearly provides 
information on an extremely compressed time-scale that seems to be comparable to an 
approximately one week long transition of a pullet to a layer bird. 
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CHAPTER V 
STATISTICAL ANALYSIS OF EXPRESSION KINETICS 
 
Introduction 
From the start of the study, it was a goal to kinetically group genes.  It was hoped 
that kinetic clustering would group genes known to be affected by the presence of 
estrogen and genes involved in VLDL assembly with genes previously unknown to act 
similarly.  The candidate gene approach was helpful for analysis focusing on 
independent time points, but it was not able to capture patterns of change in gene 
expression over time.  Thus, we sought help from statistics experts to achieve this goal. 
The hypothesis of the study was explained to the statistical experts, Dr. Scott 
Schwartz and Dr. Jiawei Wei, members of the Training program in Bioinformatics in the 
Department of Statistics at Texas A&M University.  Simply described, we gave estrogen 
to male chicks, knowing that this causes ApoB gene expression to increase.  In response, 
massive amounts of VLDLy are made.  We believe that if genes follow the same 
expression pattern as ApoB100, there is an enhanced chance that those genes may be 
specifically involved in that assembly process as well. 
By working with Dr. Scott Schwartz and Dr. Jiawei Wei, this aim was achieved 
with the creation of a novel Bayesian model based classification of temporal patterns.  
This modeling system grouped genes based on their simple kinetic patterns, and allowed 
genes some flexibility with regards to which model they fell into.  There were 243 
possible models for each gene to fall into; each of the five time points were classified as 
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up (+1), down (-1) or no change (0).  395 genes with significant q-values were included 
in this portion of analysis.  The group of 395 genes was the most highly significant 
group of genes after false discovery rate (FDR) adjustment was made.  This includes 
removing a percentage of genes with significant p-values believed to be false positives. 
Methodology (taken from Schwartz 2011 Manuscript) 
 An apparent strategy to address this question was to cluster j according to the 
vector {¯ytj : t = 1, · · · , T}, e.g., using a K-means approach [112] or a model based 
approach [113]. We initially employed both options, however, we found that clustering 
did not well discern the kinetic pattern of the elements of {¯ytj : t = 1, · · · , T}. Instead, 
clustering using these methodologies  constructed classifications on the basis of the 
overall magnitudes of the vectors. Thus, for our setting, it appeared that clustering based 
on euclidean metrics of the T dimensional variable {¯ytj : t = 1, · · · , T} was not 
conducive to distinguishing kinetic patterns in ¯ytj . Certainly, there may be some 
potential for addressing pattern identification in our setting via clustering, e.g., using 
some form of standardized data {ztj : t = 1, · · · , T}, but we do not pursue this further 
here. 
Instead, we provide a model framework that characterizes outcomes according to 
their kinetic patterns in {yitj : i = 1, · · · , n; t = 1, · · · , T}. Our methodology has three 
key components: 1. a cumulative mean changing from one time point to the next, 2. a 
variable selection prior that characterizes kinetic patterns, and 3. a hierarchical 
component that for correlated/longitudinal data. Our specification is  
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The j subscripts are retained to emphasize that the univariate data {yitj : i = 1, · · · , n; t 
= 1, · · · , T} is considered independently. Our specification results in a cumulative 
expected value for yitj that is equal to the expected value of the previous time point 
E(yi(t−1)j ) = Bij + Pt−1 k=1 βkj adjusted by some βtj .  That is, E(yitj) = E(yi(t−1)j) + 
βkj . Thus, through this parameterization, the kinetic changes from one time point to 
the next are directly captured. The inclusion of the point mass mixture prior specification 
f(βtj) of Geweke [114] allows for each modeled βtj to either increase, decrease, or not 
affect the expected value accumulated up to the previous time point. Through this 
mechanism, gene j‟s relationship to estrogen exposure over time is characterized 
according to kinetic pattern comprised of up/down/steady transitions in mRNA response 
over time. Finally, we allow each {yitj : t = 1, · · · , T} to have a unique offset Bij = β1j 
+ (Bij − β1j ). This allows the methodology to be applied to longitudinal settings or other 
settings (such as the one we describe in Section 3) where there is correlation between 
{yitj : t = 1, · · · , T}. By specifying Bij as the first level of a hierarchy centered around 
β1j , inference on the correlation is provided by (Bij − β1j ), and full kinetic inference on 
the overall intercept β1j is still available via the point mass mixture prior f(β1j ). If there 
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is no reason to expect {yitj : t = 1, · · · , T} are correlated, as in true cross-sectional data 
settings, Bij and s2j may be simply dropped from the modeling. We explore sensitivity 
of the estrogen data results to this non-correlated specification in Section 3. As always, 
the model will be sensitive to dominating specifications of the prior parameters. Of 
particular interest in this regard is the choice of p, the prior probability of each βtj being 
0. In our experience, p behaves as an analysis tuning parameter. As such, a sensitivity 
analysis over plausible values for p must be implemented to assess the influence of the 
prior specification of p on the results. For example, in our actual analysis we use a subset 
of genes expected to show temporal patterns and so we examine results for p = .5, p = .2, 
and p = .05. This corresponds to a prior belief that 50%, 20%, and 5% of the βtj are 0, 
respectively. In addition to examining sensitivity to p, because the behavior of certain 
genes in response to estrogen exposure is approximately known we may also criticize 
our selections.On a final note, we could incorporate a hierarchical information sharing 
structure by substituting ptj ∼ Beta(aθ, bθ) in place of the single parameter p.  However, 
we feel in the case of T = 5 coefficients, the status dtj of a single βtj would provide 
questionable information regarding the status dt′j of another βt′j , and so we do not 
pursue this extension. 
As noted, our approach for characterizing mRNA estrogen response is to classify 
each gene j by its kinetic pattern:{sign(βtj)dtj : t = 1, · · · , T}. That is, each gene j is 
enumerated according to a model of the form Mj = {m1j , · · · ,mtj}, where mtj ∈  {−1, 
0, 1} and t = 1, · · · , T. For example, the model, or kinetic pattern for the mRNA 
expression data displayed in Figure 1 (see appendix) appears to be MFig1 = {1, 1, 1, 
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1,−1} or up-up-up-up-down, while a gene that is not affected by estrogen should be M0 
= {0, 0, 0, 0, 0} or steady-steady-steady-steady-steady. Note that m1j represents the 
change relative to the baseline, whereas each subsequent mkj for k = 2, · · · , T 
represents the change from the previous time point. The Mj are meant to provide high 
level classification capabilities for distinguishing between various combination of 
increasing, decreasing, and steady kinetic patterns across ordinal treatment regimes t. 
Full inference on {βtj : t = 1, · · · , T} is still available for finer levels of inference, 
should they be required. Once inference on each Mj is complete, classification is 
complete, and inference on specific Mj′ may be compared to that of any other Mk, k 6= j 
for relative classification purposes. In many model selection settings, finding high 
posterior probability models is challenging. It is not a problem here however. First, for a 
small number of time points, there are not very many models, e.g., 35 = 243 when T = 5, 
and so in principal all may be examined. Second, models with high posterior probability 
are in fact easily found under this specification since each βtj is essentially estimating a 
mean. Thus, advanced stochastic search variable selection (SSVS) procedures (see, e.g., 
Hans et al. [115]) are not necessary.   
Results 
By design, there were 3
5
 (243) possible models over five time points; each of the 
395 genes with significant q-values fell into models most closely matching the gene‟s 
individual expression pattern.  Biologically, the most interesting patterns were those 
which included genes known to be related to the ApoB-LP assembly process.  These 
interesting genes include apolipoprotein B (ApoB), ApoVLDL-II, MTP, and AGPAT3, 
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among others.  Along with these noteworthy genes, it was anticipated that additional 
genes related to transport, binding, enzyme activity, and secretion might be identified by 
possession of an expression pattern that corresponded to that of ApoB.   
Analysis based upon a time course gives the ability to tease out necessary and 
possibly unknown components that enable process flow.  An early time course study by 
Janero and Lane determined that VLDL particle assembly required about 30 minutes, 
focusing on apolipoprotein, TAG, and phospholipid secretion rates [36].  Their pulse-
chase study of estrogen induced parenchymal liver cells determined that phospholipids 
were secreted 5-15 minutes into the chase and again after 30 minutes, TAGs were 
secreted 20-25 minutes into the chase, and apolipoproteins were secreted after 30-35 of 
chase time [36].  This secretion pattern gives a basic framework upon which to place 
individual genes involved in production of individual particles. 
The 395 genes with significant q-values were first analyzed using The Database 
for Annotation, Visualization and Integrated Discovery (DAVID) [92, 93].  DAVID 
recognized 101 unique genes (25.57%) and placed them into fourteen functional 
annotation clusters.  Thirteen of the fourteen functional clusters (92.86%) contained at 
least one gene ontology (GO) term containing the key word “fat”.  The cluster with the 
highest enrichment score was involved in lipid transport and lipid localization.   
 The correlated models containing ApoB contained a total of 285 genes.  The 
uncorrelated models containing ApoB contained 233 genes.  When the data were not 
correlated, ApoB statistically fell into four of the possible 243 patterns when p=0.5, one 
pattern when p=0.2 and three patterns when p=0.05.  When the data were correlated,  
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ApoB statistically fell into three patterns when p=0.5, six patterns when p=0.2 and three 
patterns when p=0.05.  At p=0.05, the expression patterns that ApoB matched were the 
same when using the correlated and non-correlated algorithms.  It was interesting that 
out of the 243 patterns, ApoB falls into a limited number of patterns; only ten patterns 
contained ApoB (4.1%).  It should be noted that apolipoprotein-B is a large protein 
(4536 amino acids long) and there are five oligonucleotide probes for ApoB on the 44K 
Agilent Chicken Array.  Only two of the five ApoB probes, M18421 and BU125204, 
had significant q-values and appeared in the analysis.  Interestingly, of the twenty 
models ApoB appeared in across the multiple model analysis, only five of these models 
were representative of both M18421 and BU125204.  These two ApoB probes had 
similar expression patterns, and together guide further comments related to ApoB.   
Several genes appeared to share the kinetic profile of ApoB, appearing in each of 
the three non-correlated groups.  One of these genes is putative porin precursor, which 
functions in ion and general cell transport.  This supports the necessity of transport 
within the cell during a massive upregulation of VLDLy production.  Another gene that 
appeared with ApoB in each of the non-correlated p groups was 1-AGPAT 2.  This gene 
is expected to be upregulated in course with ApoB, as it provides ample phospholipids to 
supply developing VLDLys.  Molybdenum cofactor sulfurase (MOCOS, E.C. 4.4.-) was 
also seen across the three non-correlated groups, probably assisting the process by acting 
as an antioxidant, as VLDL secretion is known to be impaired with oxidative stress in 
the RER [116].  Another gene that was in each of these groups was liver fatty acid 
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binding protein (FABP).  The FABPs act as carriers for fatty acids and other lipophilic 
substances between intra- and extracellular membranes.   
 Like the non-correlated groups, the putative porin precursor appeared in all three 
correlated groups, showing that the expression patterns of this transporter protein and 
ApoB are extremely similar.  Alanine aminotransferase 2 (GPT2, E.C. 2.6.1.2) was also 
seen in each of the three correlated groups.  GPT2 is an enzyme which acts to catalyze 
the reversible transamination between alanine and 2-oxoglutarate to form pyruvate and 
glutamate, processes important in gluconeogenesis and amino acid metabolism.  Fatty 
acid binding protein participates in the uptake, intracellular metabolism and transport of 
long-chain fatty acids.  This gene was seen to follow all three groups.  An interesting 
gene that was seen in this grouping was pescadillo homolog 1 (PES1).  This gene is part 
of the PeBoW complex, which is required for maturation of 28S and 5.8S ribosomal 
RNAs and the formation of the 60S ribosome.  PES 1 was unseen in any ApoB 
containing non-correlated groups, which is likely due to the stricter statistical 
requirements of the non-correlated groups as compared to the correlated groups. 
A gene expected to more closely follow ApoB was VLDL-II.  VLDL-II is an 
inhibitor of LPL, protecting the VLDLy from enzymatic breakdown and allowing the 
deposition of lipid into the developing oocyte [117].  VLDL-II may be a protein present 
in excess or the timing of its expression may be slightly different from that of ApoB.  
Another gene with interesting grouping was VTG.  VTG appeared in two correlated 
groups and in two non-correlated groups.  VTG is a phosphoprotein exclusively 
expressed in the livers of estrogenized birds that is cleaved to form the egg yolk 
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phosphoproteins, lipovitellin, and phosvitin [27].  It was seen to increase expression by 
200-fold in this microarray study.   
 Of the 31 candidate genes that were significantly expressed at one or more time 
points, only eight (26%) fell into at least one Bayesian model.  This may be because not 
all of these genes had a q-value of <0.05, and were not included Bayesian modeling.  
Several of these significantly expressed genes had two representative probes on the 
microarray.  The candidate genes included in Bayesian modeling were ApoB, AGPAT-
2, ApoVLDL-II, VTGI, FABP, RBP, CHK, and LPL.  All eight of these genes fit into at 
least one model in each of the correlated and uncorrelated p=0.05, p=0.20, and p=0.50 
significance groups.  Three genes fell into six models.  These were AGPAT-2 at the 
correlated p=0.20 level, one ApoVLDL-II probe at the correlated p=0.05 level, and 
FABP at the correlated p=0.05 level.  The only similar model between any of these three 
genes was model 105, which fit ApoVLDL-II and FABP.   
 Of the 119 genes that were differentially expressed in relation to time 0 across all 
time points, 37 of the 119 genes (31%) were not included in a correlated Bayesian model 
of any significance level.  Forty of the 119 genes (34%) were included in only one 
Bayesian model in the correlated, p=0.50 significance group.  Twenty-six of the 119 
genes (22%) were included in only one Bayesian model in the correlated, p=0.20 
significance group.  Six of the 119 genes (5%) were included in only one Bayesian 
model in the correlated, p=0.05 significance group.  Of these six groups, model 81 
appeared three times in three different genes (glypican-1 protein, claudin domain 
containing-1 protein, and unknown).  Glypican-1 is a cell surface proteoglycan that bears 
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heparin sulfate, and may regulate cell response to growth factors, cell adhesion 
molecules, and extracellular matrix components [118].    
Conclusions 
From this interaction, I learned how to convey biological messages to non-
biology scholars.  It was important that the statistics experts involved in the project 
understood the basic biology behind the project and knew our precise goals in 
proceeding with the interaction.  From this information and understanding, they would 
be able to apply appropriate statistical methodologies to the data set.   
The Bayesian modeling allowed me to classify genes based upon kinetic patterns, 
a feat otherwise not possible.  The modeling identified several genes following ApoB‟s 
kinetic pattern which were novel to our study, which were PES1, the PeBoW complex, 
and MOCOS.  It also classified several genes in groups not containing ApoB.  These 
genes were expected to be classified along with ApoB.   
It is not possible to determine the nature of the clusters at this point, but as 
annotation knowledge is furthered, determination of the functionality of the clusters may 
be possible.  This interaction was also an important stepping stone to future interactions 
with statisticians using data from future projects in the lab creating large datasets, similar 
to the dataset used in this thesis. 
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CHAPTER VI 
INTEGRATED CONCLUSIONS 
 
This study has shown that estrogen exposure using male chicks followed by 
whole genome microarray analysis produces similar results to previously done estrogen 
induction surveys as well as the events accompanying the natural onset of yolk 
formation.  As technology advances and gene annotation is added, the microarray will 
produce richer, and more extensive data.  Even with the available annotation, this 
chicken microarray project has proven to be a valuable addition to available work on 
VLDL assembly. 
As acquired, the Agilent 44K Chicken array was well annotated for 
immunological and cytokine genes.  In the course of this study, extensive translation of 
feature IDs to current GenBank ID‟s was done.  In addition, annotation of unknown 
feature IDs was added to the array list.  One gene of interest, THRSP, was extensively 
searched using the map viewer and BLAST.  It was determined that THRSP has the 
GenBank accession AJ719312 and its alias, LXR, was listed on the 44K array probe list.   
A candidate gene list was created in this microarray study as a starting point to 
assess the alignment of array results with pertinent findings in published literature.  This 
turned out to be a useful tool, as it showed us that estrogen induction in the male chick 
produces similar, but not exactly identical results to those shown in the murine “knock-
out” literature. 
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Indeed, several genes reported in the literature to be necessary to produce 
functional VLDL were not seen to be differentially expressed in relation to time 0 in the 
estrogen induced chick model.  There are several hypotheses on this seeming 
disagreement.  First, the chicken is a primordial organism that is functionally different 
from the models most used in the studies included in the candidate gene list, i.e. human 
cell cultures, murine, and rat models.  This evolutionary difference may be one reason 
for the difference in VLDL assembly between chickens and other models.  Second, there 
may have been experimental factors that caused the gene expression patterns in the 
estrogen induced chicks to behave differently than the literature proposes.  These factors 
include feeding and fasting states, age of the chicks, sex of the chicks, and time of day of 
harvest.  Specifically, the number of estrogen receptors in a chick‟s liver increases from 
1000 receptors per cell at 1 week after hatch, to 3,500 receptors per cell 6 weeks after 
hatch [119].  In addition, gene knock out studies are “all or nothing” examples of gene 
expression.  In a natural setting such as the one presented, genes may be permissive, 
expressed at low levels at all times, or controlling, with expression playing a regulatory 
role.     
By comparing the microarray data from the estrogen induced male chicks and q-
RTPCR data from female chickens during the pullet/layer transition, it was observed that 
the massively upregulated genes in the estrogen induced chick model behaved similarly 
in both models.  It is important to note that q-RTPCR is a significantly more sensitive 
tool than microarrays, and there was a “cut-off” limit for highly upregulated genes in the 
microarray study.  This means that q-RTPCR fold changes had the potential to be much 
89 
 
greater than microarray data for the same gene.  VTGII was one such massively 
upregulated gene; it was included in the 17 genes tested using q-RTPCR.  In the estrogen 
induced chick model using microarray, VTGII had a fold change of 227 at its peak at 6 
hours; using q-RTPCR in the transition pullets, VTGII had a fold change of 1653 when 
the pre-production and laying hens were compared.  At its peak of 6 hours, ApoVLDL-II 
had a fold change of 177 using microarray.  ApoVLDL-II had a fold change of 195 when 
pre-production and laying hens were compared using q-RTPCR.  RBP had a peak fold 
change of 59 at 12 hours using microarray; using q-RTPCR, RBP had a fold change of 
852 when pre-production and laying hens were compared. 
Across all microarray and q-RTPCR surveys, ApoB100, interestingly, had 
different expression patterns related to the location of the probe within the nucleotide 
sequence.  This may be due to efficiency of the methods used, chaperone availability, or 
factors specific to the ApoB100 sequence, but it is beyond the scope of this thesis to 
decipher this variance.   
When the q-RTPCR data from the estrogen induced chicks and data from the 
laying hens was compared, it was observed that the same genes with huge fold changes 
in the chicks had similar results in the hens.  When comparing q-RTPCR data, the 
estrogen induced chick model at 3 hrs showed VTGII had a fold change of 850; VTGII 
had a fold change of 1653 when the pre-production and laying hens were compared.  At 
its peak of 6 hrs, ApoVLDL-II had a fold change of 7430 using q-RTPCR.  ApoVLDL-
II had a fold change of 195 when pre-production and laying hens were compared using 
q-RTPCR.  RBP had a peak fold change of 34 at 6 hours using q-RTPCR; using the 
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same technology, RBP had a fold change of 852 when pre-production and laying hens 
were compared.   
In addition, we were able to show that estrogen induced male chicks exhibit 
similar expression patterns to hens in a pullet to layer transition.  Gene expression from 
1.5 to 6 hrs after estrogen introduction closely mirrored the gene expression patterns 
seen in a hen transitioning from a pullet to a layer.  In a very compressed time-scale, the 
estrogen induced chick model was able to mirror the genetic regulation of the 
approximately one week long transition of a pullet to a layer hen. 
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APPENDIX A 
GLOSSARY OF GENES DISCUSSED 
 
ApoB - This gene product is the main apolipoprotein of chylomicrons and low density 
lipoproteins. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the 
former is synthesized exclusively in the gut and the latter in the liver. The intestinal and 
the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. 
The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is 
produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), 
resulting in the creation of a stop codon, and early translation termination. Mutations in 
this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic 
hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, 
diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq]. 
 
Vitellogenin – estrogen responsive gene in oviparous species that binds PL and zinc, is 
deposited in egg yolk. 
 
Riboflavin Binding Protein – an estrogen responsive gene in oviparous species. The 
protein encoded by this gene acts to carry riboflavin into the yolk. Associates with HDL 
and VTG for transport into the follicle. 
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ApoVLDL-II – an estrogen responsive gene in oviparous species. Encodes a protein that 
becomes incorporated in the surface of VLDL particles and inhibits lipase. Is also 
thought to mediate a decrease in VLDL particle diameter. 
 
MTP - MTP encodes the large subunit of the heterodimeric microsomal triglyceride 
transfer protein. Protein disulfide isomerase (PDI) completes the heterodimeric 
microsomal triglyceride transfer protein, which has been shown to play a central role in 
lipoprotein assembly. Mutations in MTP can cause abetalipoproteinemia. [provided by 
RefSeq]. 
 
Clock - This gene encodes a protein that belongs to the basic helix-loop-helix (bHLH) 
family of transcription factors. Polymorphisms within the encoded protein have been 
associated with circadian rhythm sleep disorders. A similar protein in mice is a circadian 
regulator that acts as a transcription factor and forms a heterodimer with aryl 
hydrocarbon receptor nuclear translocator-like to activate transcription of mouse period 
1. [provided by RefSeq]. 
 
PER2 - This gene is a member of the Period family of genes and is expressed in a 
circadian pattern in the suprachiasmatic nucleus, the primary circadian pacemaker in the 
mammalian brain. Genes in this family encode components of the circadian rhythms of 
locomotor activity, metabolism, and behavior. Circadian expression in the 
suprachiasmatic nucleus continues in constant darkness, and a shift in the light/dark 
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cycle evokes a proportional shift of gene expression in the suprachiasmatic nucleus. The 
specific function of this gene is not yet known. [provided by RefSeq]. 
 
Bmal-1 - The protein encoded by this gene is a basic helix-loop-helix protein that forms 
a heterodimer with CLOCK. This complex binds an E-box upstream of the PER1 gene, 
activating this gene and possibly other circadian rhythym-associated genes. Three 
transcript variants encoding two different isoforms have been found for this gene. 
[provided by RefSeq]. 
 
Cry1 – part of clock gene complex that controls circadian rhythms. 
 
Cry2 – cryptochrome 2 (photolyase-like); part of clock gene complex that controls 
circadian rhythms. 
 
SCAP - This gene encodes a protein with a sterol sensing domain (SSD) and seven WD 
domains. In the presence of cholesterol, this protein binds to sterol regulatory element 
binding proteins (SREBPs) and mediates their transport from the ER to the Golgi. The 
SREBPs are then proteolytically cleaved and regulate sterol biosynthesis. [provided by 
RefSeq]. 
 
INSIG2 - The protein encoded by this gene is highly similar to the protein product 
encoded by gene INSIG1. Both INSIG1 protein and this protein are endoplasmic 
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reticulum proteins that block the processing of sterol regulatory element binding proteins 
(SREBPs) by binding to SREBP cleavage-activating protein (SCAP), and thus prevent 
SCAP from escorting SREBPs to the Golgi. [provided by RefSeq]. 
 
SREBP-1 - This gene encodes a transcription factor that binds to the sterol regulatory 
element-1 (SRE1), which is a decamer flanking the low density lipoprotein receptor gene 
and some genes involved in sterol biosynthesis. The protein is synthesized as a precursor 
that is attached to the nuclear membrane and endoplasmic reticulum. Following 
cleavage, the mature protein translocates to the nucleus and activates transcription by 
binding to the SRE1. Sterols inhibit the cleavage of the precursor, and the mature 
nuclear form is rapidly catabolized, thereby reducing transcription. The protein is a 
member of the basic helix-loop-helix-leucine zipper (bHLH-Zip) transcription factor 
family. This gene is located within the Smith-Magenis syndrome region on chromosome 
17. Two transcript variants encoding different isoforms have been found for this gene. 
[provided by RefSeq]. 
 
SREBP-2 - This gene encodes a ubiquitously expressed transcription factor that controls 
cholesterol homeostasis by stimulating transcription of sterol-regulated genes. The 
encoded protein contains a basic helix-loop-helix-leucine zipper (bHLH-Zip) domain. 
[provided by RefSeq]. 
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UBDX8 – official gene symbol replaced by FAF2; The protein encoded by this gene is 
highly expressed in peripheral blood of patients with atopic dermatitis (AD), compared 
to normal individuals. It may play a role in regulating the resistance to apoptosis that is 
observed in T cells and eosinophils of AD patients. [provided by RefSeq] From PNAS 
108(31):2010 Ubxd8 inhibits TG synthesis by blocking conversion of diacylglycerols 
(DAGs) to TGs. Excess unsaturated but not saturated FAs relieve this inhibition. As a 
result, unsaturated FAs are incorporated into TGs, whereas saturated FAs are 
incorporated into DAGs. In vitro, unsaturated but not saturated FAs alter the structure of 
purified recombinant Ubxd8 as monitored by changes in its thermal stability, trypsin 
cleavage pattern, and oligomerization. These results suggest that Ubxd8 acts as a brake 
that limits TG synthesis, and this brake is released when its structure is altered by 
exposure to unsaturated FAs. 
 
Choline Kinase - Choline kinase (CK) and ethanolamine kinase (EK) catalyze the 
phosphorylation of choline/ethanolamine to phosphocholine/phosphoethanolamine. This 
is the first enzyme in the biosynthesis of phosphatidylcholine/phosphatidylethanolamine 
in all animal cells. The highly purified CKs from mammalian sources and their 
recombinant gene products have been shown to have EK activity also, indicating that 
both activities reside on the same protein. The choline kinase-like protein encoded by 
CHKL belongs to the choline/ethanolamine kinase family; however, its exact function is 
not known. Read-through transcripts are expressed from this locus that include exons 
from the downstream CPT1B locus. [provided by RefSeq]. 
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DGAT2 - Acyl-CoA:diacylglycerol acyltransferase, or DGAT (EC 2.3.1.20), is 
responsible for the synthesis of triglycerides. It catalyzes a reaction in which 
diacylglycerol is covalently joined to long chain fatty acyl-CoAs [supplied by OMIM]. 
 
AGPAT-3 - 1-acylglycerol-3-phosphate O-acyltransferase 3; The protein encoded by 
this gene is an acyltransferase that converts lysophosphatidic acid into phosphatidic acid, 
which is the second step in the de novo phospholipid biosynthetic pathway. The encoded 
protein may be an integral membrane protein. Two transcript variants encoding the same 
protein have been found for this gene. [provided by RefSeq]. 
 
AGPAT-2 - 1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid 
acyltransferase, beta) This gene encodes a member of the 1-acylglycerol-3-phosphate O-
acyltransferase family. The protein is located within the endoplasmic reticulum 
membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de 
novo phospholipid biosynthesis. Mutations in this gene have been associated with 
congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease 
characterized by a near absence of adipose tissue and severe insulin resistance. Alternate 
transcriptional splice variants, encoding different isoforms, have been characterized. 
[provided by RefSeq]. 
 
PEMT - phosphatidylethanolamine N-methyltransferase; This gene encodes an enzyme 
which converts phosphatidylethanolamine to phosphatidylcholine by sequential 
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methylation in the liver. The protein localizes to the endoplasmic reticulum and 
mitochondria-associated membranes. The gene is within the Smith-Magenis syndrome 
region on chromosome 17. Alternate splicing of this gene results in three transcript 
variants encoding two different isoforms. [provided by RefSeq]. 
 
Alpha Tocopherol Associated Protein - SEC14-like 2 (S. cerevisiae). This gene 
encodes a cytosolic protein which belongs to a family of lipid-binding proteins including 
Sec14p, alpha-tocopherol transfer protein, and cellular retinol-binding protein. The 
encoded protein stimulates squalene monooxygenase which is a downstream enzyme in 
the cholesterol biosynthetic pathway. Alternatively spliced transcript variants encoding 
different isoforms have been identified for this gene. [provided by RefSeq]. 
 
FABP - The intracellular fatty acid-binding proteins (FABPs) belongs to a multigene 
family. FABPs are divided into at least three distinct types, namely the hepatic-, 
intestinal- and cardiac-type. They form 14-15 kDa proteins and are thought to participate 
in the uptake, intracellular metabolism and/or transport of long-chain fatty acids. They 
may also be responsible in the modulation of cell growth and proliferation. Fatty acid-
binding protein 3 gene contains four exons and its function is to arrest growth of 
mammary epithelial cells. This gene is a candidate tumor suppressor gene for human 
breast cancer. [provided by RefSeq]. 
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Fatty Acid Synthase - The enzyme encoded by this gene is a multifunctional protein. Its 
main function is to catalyze the synthesis of palmitate from acetyl-CoA and malonyl-
CoA, in the presence of NADPH, into long-chain saturated fatty acids. In some cancer 
cell lines, this protein has been found to be fused with estrogen receptor-alpha (ER-
alpha), in which the N-terminus of FAS is fused in-frame with the C-terminus of ER-
alpha. [provided by RefSeq]. 
 
ATP Citrate Lyase - ATP citrate lyase is the primary enzyme responsible for the 
synthesis of cytosolic acetyl-CoA in many tissues. The enzyme is a tetramer (relative 
molecular weight approximately 440,000) of apparently identical subunits. It catalyzes 
the formation of acetyl-CoA and oxaloacetate from citrate and CoA with a concomitant 
hydrolysis of ATP to ADP and phosphate. The product, acetyl-CoA, serves several 
important biosynthetic pathways, including lipogenesis and cholesterogenesis. In 
nervous tissue, ATP citrate-lyase may be involved in the biosynthesis of acetylcholine. 
Two transcript variants encoding distinct isoforms have been identified for this gene. 
[provided by RefSeq]. 
 
Stearoyl CoA Desaturase - Stearoyl-CoA desaturase (SCD; EC 1.14.99.5) is an iron-
containing enzyme that catalyzes a rate-limiting step in the synthesis of unsaturated fatty 
acids. The principal product of SCD is oleic acid, which is formed by desaturation of 
stearic acid. The ratio of stearic acid to oleic acid has been implicated in the regulation 
116 
 
of cell growth and differentiation through effects on cell membrane fluidity and signal 
transduction.  
 
Fatty Acid Elongase - ELOVL5 plays a role in elongation of long-chain 
polyunsaturated fatty acids (Leonard et al., 2000 [PubMed 10970790]).[supplied by 
OMIM]. 
 
PGD - 6-phosphogluconate Dehydrogenase - 6-phosphogluconate dehydrogenase is 
the second dehydrogenase in the pentose phosphate shunt. Deficiency of this enzyme is 
generally asymptomatic, and the inheritance of this disorder is autosomal dominant. 
Hemolysis results from combined deficiency of 6-phosphogluconate dehydrogenase and 
6-phosphogluconolactonase suggesting a synergism of the two enzymopathies. [provided 
by RefSeq]. 
 
AMP-K - protein kinase that phosphorylates and inhibits acetyl-CoA carboxylase 
(ACC); rate-limiting enzyme in malonyl-CoA synthesis [RGD]. 
 
FADS2 - The protein encoded by this gene is a member of the fatty acid desaturase 
(FADS) gene family. Desaturase enzymes regulate unsaturation of fatty acids through 
the introduction of double bonds between defined carbons of the fatty acyl chain. FADS 
family members are considered fusion products composed of an N-terminal cytochrome 
b5-like domain and a C-terminal multiple membrane-spanning desaturase portion, both 
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of which are characterized by conserved histidine motifs. This gene is clustered with 
family members FADS1 and FADS2 at 11q12-q13.1; this cluster is thought to have 
arisen evolutionarily from gene duplication based on its similar exon/intron organization. 
[provided by RefSeq]. 
 
FADS1 - The protein encoded by this gene is a member of the fatty acid desaturase 
(FADS) gene family. Desaturase enzymes regulate unsaturation of fatty acids through 
the introduction of double bonds between defined carbons of the fatty acyl chain. FADS 
family members are considered fusion products composed of an N-terminal cytochrome 
b5-like domain and a C-terminal multiple membrane-spanning desaturase portion, both 
of which are characterized by conserved histidine motifs. This gene is clustered with 
family members FADS1 and FADS2 at 11q12-q13.1; this cluster is thought to have 
arisen evolutionarily from gene duplication based on its similar exon/intron organization. 
[provided by RefSeq]. 
 
ACAT - Acyl-coenzyme A:cholesterol acyltransferase (ACACT; EC 2.3.1.26) is an 
intracellular protein located in the endoplasmic reticulum that forms cholesterol esters 
from cholesterol. Accumulation of cholesterol esters as cytoplasmic lipid droplets within 
macrophages and smooth muscle cells is a characteristic feature of the early stages of 
atherosclerotic plaques (Cadigan et al., 1988 [PubMed 3335499]).[supplied by OMIM]. 
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ACAT 2 - This gene is a member of a small family of acyl coenzyme A:cholesterol 
acyltransferases. The gene encodes a membrane-bound enzyme localized in the 
endoplasmic reticulum that produces intracellular cholesterol esters from long-chain 
fatty acyl CoA and cholesterol. The cholesterol esters are then stored as cytoplasmic 
lipid droplets inside the cell. The enzyme is implicated in cholesterol absorption in the 
intestine and in the assembly and secretion of apolipoprotein B-containing lipoproteins 
such as very low density lipoprotein (VLDL). Several alternatively spliced transcript 
variants of this gene have been described, but their full-length nature is not known. 
[provided by RefSeq]. 
 
Lipin - This gene represents a candidate gene for human lipodystrophy, characterized by 
loss of body fat, fatty liver, hypertriglyceridemia, and insulin resistance. Mouse studies 
suggest that this gene functions during normal adipose tissue development and may also 
play a role in human triglyceride metabolism. [provided by RefSeq]. 
 
PeBoW Complex - A protein complex that is involved in coordinating ribosome 
biogenesis with cell cycle progression. In human, it is composed of Pes1, Bop1, and 
WDR12; in Saccharomyces the proteins are known as Nop7p, Erb1 and Ytm1 
respectively. 
 
PES1 - This gene encodes a nuclear protein that contains a breast cancer associated gene 
1 (BRCA1) C-terminal interaction domain. The encoded protein interacts with BOP1 
119 
 
and WDR12 to form the PeBoW complex, which plays a critical role in cell proliferation 
via pre-rRNA processing and 60S ribosomal subunit maturation. Expression of this gene 
may play an important role in breast cancer proliferation and tumorigenicity. 
Alternatively spliced transcript variants encoding multiple isoforms have been observed 
for this gene. Pseudogenes of this gene are located on the long arm of chromosome 4 and 
the short arm of chromosome 9. [provided by RefSeq]. 
 
MOCOW - This gene encodes a nuclear protein that contains a breast cancer associated 
gene 1 (BRCA1) C-terminal interaction domain. The encoded protein interacts with 
BOP1 and WDR12 to form the PeBoW complex, which plays a critical role in cell 
proliferation via pre-rRNA processing and 60S ribosomal subunit maturation. 
Expression of this gene may play an important role in breast cancer proliferation and 
tumorigenicity. Alternatively spliced transcript variants encoding multiple isoforms have 
been observed for this gene. Pseudogenes of this gene are located on the long arm of 
chromosome 4 and the short arm of chromosome 9. [provided by RefSeq]. 
 
WDR12 - This gene encodes a member of the WD repeat protein family. WD repeats 
are minimally conserved regions of approximately 40 amino acids typically bracketed by 
gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or 
multiprotein complexes. Members of this family are involved in a variety of cellular 
processes, including cell cycle progression, signal transduction, apoptosis, and gene 
regulation. This protein is highly similar to the mouse WD repeat domain 12 protein at 
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the amino acid level. The protein encoded by this gene is a component of a nucleolar 
protein complex that affects maturation of the large ribosomal subunit. 
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